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Cold-hearted orb that rules the night  
Removes the colours from our sight,  
Red is grey and yellow white  
But we decide which is right  
And which is an illusion.  
The Moody Blues 
 Table of contents 
 
 
 
Chapter 1  General introduction      7 
 
 
Chapter 2  Induced refolding of a temperature denatured  25 
llama heavy chain antibody fragment by its antigen 
 
Chapter 3  Applied phage display in harsh detergent   47 
conditions: implications for antibody stability   
 
Chapter 4 Decreasing trypsin susceptibility of single domain  71 
antibodies: implications for structural stability 
 
Chapter 5 Comparison of VH and VHH domains on   89 
sequence level; adaptations of the VHH   
to the lack of VL 
 
Chapter 6 General discussion     103 
 
 
Summary        110 
 
 
Samenvatting        112 
 
 
Dankwoord        114 
 
 
Curriculum vitae       117 
 
 
 
Chapter 1 
 
 
 
 
General Introduction 
 
 
 
 
 
 
 
 
                                                                                        General introduction 
                                                                                           
 9 
General introduction 
Immune system 
The immune system is of great importance for the defence of our body against 
invasion of pathogens, like viruses and bacteria. The importance is best illustrated by the 
result of a defect in the immune system, for instance after infection with a virus impairing 
the immune system, like HIV (the AIDS virus) of which we all know the dramatic 
consequences. 
The immune system discriminates two defence mechanisms, which are integrated 
to form a complex defence system. The innate or native immunity, which is the first  line of 
defence, and adaptive immunity, which adapts to and develops an immune response to 
infection or intrusion of the body.  
The innate immunity consists of several basic mechanisms to inhibit a rapid and 
not very selective first line of defence. To these mechanisms belong the mucosal layers of 
the intestine, epithelia, and the inflammatory reaction as non-selective barriers. Also, 
phagocytic cells, the complement system, and a variety of other effector cells, which are 
coordinated by cytokines. The main difference with adaptive immunity is that innate 
immunity responds in a similar way to repetitive infection. Adaptive immunity on the other 
hand adapts its response during repeated exposure and evolves a highly specific response to 
the specific intruder. 
The adaptive immune system has several defence mechanisms. One mechanism is 
known as cell-mediated immunity and is particularly effective against invaded viruses, 
parasites and cancer cells. T-cells mediate the recognition of these abnormal cells in the 
body and destroy them by activation of a series of effector cells, like killer T-cells. Another 
mechanism is called humoral immunity and is particularly directed against extracellular 
bacteria and viruses. Here, B-cells and helper T-cells recognize foreign molecules resulting 
in the secretion of specific antibodies in the blood. Antibodies specifically bind to the 
foreign molecules (antigens) in the body. Although the antigens (antibody generators) need 
to be large (>10kDa) to provoke an immune response, the antibody binds to only a small 
part of the antigen, the epitope. Binding of the antibodies to these antigens causes the 
destruction of the foreign molecule by macrophages or complement system. 
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variable domain and the first constant 
igure 1 Schematic representation of an IgG. In light gray 
hains with a variable domain (VL) and a constant 
Antibodies are also referred to as immunoglobulins (Ig), because of the globular 
structure seen in all subdomains of the antibodies. Five classes of immunoglobulins: IgA, 
IgD, IgE, IgG and IgM are found. The different classes have different structures according 
to their function in the body. IgM and IgD are in membrane-bound form on naive B-cells. 
They have a major role in the antibody response in the blood. 
IgA is responsible for the first line of defence outside the blood stream, for 
instance in saliva or the mucosal layers of the intestine. Two subclasses of IgA have been 
found, IgA1 and IgA2, of which IgA1 is most abundant. IgE is less abundant and has a 
function in the defence against parasites and plays a role in allergy. IgG is relatively 
abundant and is especially important for the secondary immune response. Four isotypic 
subclasses of IgG are now known, IgG1, IgG2, IgG3, and IgG4, which are different in 
structure and therefore the different subclasses have specific functions. They can all 
develop high affinity binding to their antigen and have a lot of secondary biological 
functions. This makes IgG the working ant of the immune system.  
 
Structure of antibodies 
IgG comprises four polypeptide chains. Two identical heavy (H) chains and two 
identical light (L) chains. These chains are linked by disulphide bonds to form a functional 
antibody. The peptide chains are made up of related domains. The light chain consists of 
two domains, a constant domain and a variable domain. The heavy chain is more complex 
and consists of several domains depending on the isotype. IgG heavy chains consist of a 
domain combined by a flexible linker to two constant 
domains (see figure 1). Soluble IgD heavy chains 
resemble IgG. IgA and IgM also resemble IgG, but 
IgA can form dimers, and IgM can form pentamers, 
both linked by an extra domain or J-chain. IgE heavy 
chains consist of five domains, with CH4 as an extra 
domain. 
 
F
the light c
domain (CL). In dark gray the variable domain of the 
heavy chain (VH) and in white the constant domains of the 
heavy chain (CH). 
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ndependently for 
heavy a
the light chain to the heavy chain results in displacement of the BiP protein and in the 
of the heavy chains and at the same time presenting them to the light chain.  
domains, 
interacti
(CDRs). These loops are in direct contact with the antigen and determine the specificity of 
the antibody. These binding loops are grafted on a double -sheet ‘sandwich’ structure 
 
Llama heavy chain antibodies 
The antibodies as described above are present in all animals and will be referred to 
as conventional antibodies. However, for camelids (Hamers-Casterman, 1993), wobbegong 
the heavy chains of conventional antibodies and are therefore referred to as heavy chain 
edaries and camels in the family of the Camilidae are the only 
species o
closely related taxonomic suborders, like Ruminantia (giraffe, sheep) or Suiformes (swines, 
have evolved independently from those of the ratfish and nurse shark and are not a remnant 
of evolution but emerged from the conventional antibodies (Nguyen, 2002).   
Folding of the polypeptide chains begins in the ER and occurs i
nd light chains, and thus before assembly. As a quality control system the BiP 
protein is associated to the first constant domain of the heavy chain (CH1) (Knarr, 1995), 
preventing aggregation and  causing retention in the ER (Hendershot, 1987). Association of 
secretion of the complete antibody from the ER via the Golgi to the extracellular space 
(Hendershot, 1990). In this process, formation of disulphide bridges results in a stable 
antibody as shown in figure1. This shows the dual role of BiP, first preventing aggregation 
This assembly of heavy and light chain results in two adjacent variable 
ng to form the antigen binding domains. Within these variable domains three 
regions of high variability could be recognized, the complementarity determining regions 
β
typical for antibodies, called the framework. 
or nurse sharks (Greenberg, 1995) and spotted ratfish (Rast, 1998) it has been shown that 
they also posses a structurally different kind of antibodies next to conventional antibodies. 
These antibodies are composed of only two identical heavy polypeptide chains, resembling 
antibodies (HCAbs).  
Llamas, drom
f the suborder of the Tylopodia. Heavy chain antibodies have not been reported in 
hippopotamuses) of the order of Artiodactyla, to which the Tylopodia belong (Conrath, 
2003) (see figure 2). This shows that the heavy chain antibodies have evolved a relatively 
short time ago (16-18 million years) (Conrath, 2003). The camelid heavy chain antibodies  
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Figure 2 Phylogenetic  
tree of the  order  
 
The heavy chains of the HCAbs lack the first constant region (Ch1). The CH1 
genes in camelids have a mutation at the canonical splicin site, which is responsible for 
the loss 
 
 
 
 
 
 
 
Artiodactyla. 
 
 
g 
of the first constant domain in the heavy chain antibodies. The BiP protein can no 
longer attach to the heavy chains, to combine them with the light chains. This might be the 
crucial step in the emergence of heavy chain antibodies (Nguyen, 2002). The two remaining 
constant domains are coupled to the variable domain by a flexible linker or hinge (see 
figure 3). This variable region is, by the lack of the light chain, also the only domain 
responsible for binding to the antigen. This variable domain of the heavy chain of heavy 
chain antibodies is called VHH (see figure 3).  
 
 
 
igure
 
 
 3  
epresent  of a 
l 
F
R ation
aconvention
antibody and a 
heavy chain 
antibody.  
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ngineered antibody fragments 
to two antigen binding fragments (Fab) and a 
crystallizable fragment (Fc) or effector fragment (see figure 3). The Fab fragments of 
conventi
calins, which are small secreted proteins with certain 
immuno
able domain of the heavy 
chain of
VHH sp
E
An antibody can be divided in
onal antibodies consist of two variable domains and two constant domains, which 
can still bind specifically to an antigen. An even smaller binding unit consists of only the 
two variable domains (VH-VL) combined by a linker, the single chain variable fragment 
(ScFv) (see figure 3). VHHs derived from heavy chain antibodies are the smallest naturally 
occurring binding domains. 
The benefits of small binding units have been recognized and are now emerging 
rapidly. For instance lipo
modulatory effects are now being used as an alternative for antibodies (Skerra, 
2001). These single domain ‘anticalins’ are able to bind a wide diversity of molecules, 
resembling  recombinant antibody fragments (Schlehuber, 2002). 
The llama VHH domain is transcribed from a separate set of genes (Nguyen, 
2000) and VHHs thus have unique properties compared to the vari
 conventional antibodies (VH) (Harmsen, 2000). Four residues, Val37, Gly44, 
Leu45 and Trp47 (Kabat numbering is used throughout (Kabat, 1991)), are highly 
conserved in VHs. These residues are in the hydrophobic patch which interacts with the 
VL, and are constitutively substituted in the VHHs into Phe/Tyr37, Glu44, Arg45 and 
Phe/Leu/Gly47 (reviewed in Muyldermans, 2001). These substitutions make the 
hydrophobic interface more hydrophilic and are specific for VHHs, and are therefore 
recognized as hallmarks for VHHs. They render the VHH more soluble, thereby showing 
adaptation to their single domain status. This adaptation is necessary for compensation of 
the loss of stability induced by the lack of VL. Since local unfolding is usually the start of 
denaturation induced by negative influences, like high temperature and denaturants, the 
VHH is susceptible for these influences. Local unfolding in the single domain can easily 
result in global unfolding, where the paired domains of VH and VL can stabilize each other. 
Several features have been shown to enlarge the diversity of the VHH repertoire to 
compensate for the lack of the VL domain in the binding to the antigen. A large subset of 
ecific germline genes, together with a longer CDR3, and more residues involved in 
binding of the antigen lead to an enhanced repertoire. The longer CDR3 not only leads to a 
increase in binding repertoire, but also gives the VHH a higher structural complexity, and 
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es in biology and the industry 
une response in the body. Their major 
function, the specific and high affinity binding to any given antigen, make them well 
appreciat
nostic tests to detect small amounts of drugs or 
hormone
therefore have more abilities in binding the antigen. The long CDR3 is reported to 
efficiently protrude into the active site clefts of enzymes (Transue, 1998; Lauwereys, 1998), 
form cavities for hapten binding (Spinelli, 2000) and show lateral recognition of the antigen 
(Spinelli, 2001). CDR3 alone was shown able to bind specific to and with high affinity to 
the antigen (Desmyter, 2001). In general more residues are involved in antigen binding, not 
only as a result of a longer CDR3, but also because of more incidences of framework 
residues involved in antigen binding (Spinelli, 2001). Together with a high diversity of 
specific VHH genes (Nguyen, 2000), this leads to a high diversity of antigen binding 
capacity.  
 
Antibodi
Antibodies are key players in the imm
ed in practically all disciplines of biology. Detection of protein bands on a 
Western blot with specific antibodies is used in all the molecular biology and biochemistry 
labs, and nowadays even antibody arrays (Zhu, 2000; Haab, 2003) are just two applications 
in which antibodies are well established.  
In the industry the applications using antibody technology are rising rapidly as 
well. Antibodies are used in several diag
s, e.g. monoclonal antibodies to human chorionic gonadotropin (HCG) are used in 
OTC pregnancy test kits (Porter, 1988). In medicine, antibodies are used as fusion proteins, 
to function as a carrier to target specific effector substances to a specific location, the so-
called ‘magic bullet’ approach (Joosten, 2003). Cancer therapy is one of the promising 
applications for the use of antibodies with this ‘magic bullet’ approach (Boleti, 1995). 
Antibodies have also proven their usefulness in radioimmunodetection and 
radioimmunotherapy of cancer (Funaro, 2000; Goodwin, 2001; Roovers, 2001), in which 
the small, easily penetrating VHHs might have an advantage over conventional antibodies 
(Cortez-Retamozo, 2002). Oral or intravenous administration of antibodies are used for the 
treatment of various diseases, like Huntington’s disease by inhibition of aggregation of 
huntingtin (Heiser, 2000). The direct inhibition of rotavirus by oral administration of 
antibodies is another example of an application for antibodies in therapeutics (Hilpert, 
1987). A drawback recognized by Heiser et al (2000), Hilpert et al (1987) and many other 
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hibiting 
aggregat
he yeast Saccharomyces cerevisiae. The 
high lev
roperties 
of VHH
researchers is the decreased functionality of antibodies in vivo. They may be degraded by 
proteases, have a poor blood–brain permeability, are unable to reach their target protein, or 
are simply not functional in vivo, because of physical limitations of the antibodies. 
In this respect the VHHs are now emerging and more and more researchers 
recognize the advantages and possibilities of these small natural binding blocks. In
ion of human lysozyme by binding of VHHs to decrease fibril and plaque 
formation seen in amyloid diseases (Dumoulin, 2003) and the detection and 
characterization of other diseases, like another aggregation associated disease, 
oculopharyngeal muscular dystrophy (OPMD) (van Koningsbruggen, 2003) shows that 
VHHs can be very useful for therapeutic purposes. The direct monovalent inhibition of 
enzymes and viruses shows the potential of these antibody fragments (Stijlemans, 2003; 
Dekker, 2003; Van der Vaart, in preparation), even across the blood-brain barrier 
(Muruganandam, 2002) or in the gastrointestinal tract (Dolk, in preparation). In electron 
microscopy the easily penetratable VHHs can be used to detect and localize proteins, like 
the baseplate protein ORF18 of lactococcal bacteriophage p2, which is involved in 
adsorption to cell surface receptors (Ledeboer, 2002; de Haard, accepted for publication), 
and in other applications like  immunoprecipitation, and immunoaffinity purification they 
have proven their functionality (Verheesen, 2003). 
One of the reasons for the interest of the industry in VHHs is that the single 
domain allows production in microorganisms, like t
els of production and the subsequent purification is very efficient, which enables 
cheap production of large quantities of VHHs (Frenken, 2000; Thomassen, 2002). 
One of the most prominent advantages of VHHs over conventional antibodies is 
their performance at high temperatures. Van der Linden reported on the excellent p
s at high temperatures, showing VHHs can endure incubations of two hours at up to 
90 ºC. Some VHHs were even able to bind to their antigen at 90 ºC (Van der Linden, 1999). 
Perez showed that temperature denatured unfolding was reversible and functional VHHs 
were present after cooling down (Perez, 2001). This reversibility of unfolding was also 
shown at 80 ºC, induced by the antigen (Dolk, in preparation). This shows that the stability 
of the antibody-antigen complex can result in the refolding of the VHH. High temperatures 
up to 70°C necessary for pasteurisation of food products and even higher temperatures up 
to 120°C for sterilization of diagnostic tools with VHHs belong to the possibilities with 
Chapter 1                                                                                                        _ 
 
 16
Since stability of VHHs is the major topic of this thesis, it is important to have a 
alled stability. The definition of stability in the dictionary is: 
“the qua
consider
 
temperat
VHHs. Whereas conventional antibodies would loose significant functionality, because of 
irreversible unfolding. These observations explain the apparent high intrinsic stability of the 
VHHs. Altogether the easy cloning, cheap production and high stability make VHHs very 
useful for a wide range of applications. 
 
Definition of stability 
clear definition of what is c
lity or attribute of being firm and steadfast” and the definition of stableness is: “the 
quality of being steady or securely and immovably fixed in place”. In biology stableness or 
stability might mean just the opposite. To explain this contradiction and to clarify what 
stability means in this thesis, we have to consider the differences in determination of the 
stability of a protein. In this respect, we can distinguish two kinds of stability, intrinsic 
stability and functional stability. The intrinsic stability of a protein in a certain environment 
is simply the difference in Gibbs free energy, ∆G, between the folded and the unfolded state 
of the protein defined by the enthalpy, the entropy and the temperature (∆G = ∆H - T∆S). 
On the other hand, the functional stability will be defined as the ability of the 
protein to function under the given conditions. This definition of stability does not only 
 the intrinsic stability of a protein but also the kinetic stability of a protein. A 
protein that is completely unfolded at high temperature, but for instance by reversible 
folding, is fully functionality, will be considered stable by the latter definition, but should 
be considered thermo-unstable. Aggregation, proteolysis and chemical degradation are 
factors that will decrease stability of proteins denaturing reversible. In this case flexibility 
and reversibility will be parameters that define stability. This could be considered the 
opposite of the definition given by the dictionary: “immovably fixed in place”. 
In this thesis the term stability will be used as functional stability under the given 
conditions. An increase in stability implicates that the protein is more functional at a certain
ure or concentration of denaturant, compared to another protein. It could also 
implicate that the protein is able to maintain the same functionality at higher temperatures 
or at higher concentrations of denaturants compared to another protein. 
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erties from a large collection of VHH, 
phage display is performed (Hoogenboom, 1998). Phage display uses bacteria and bacterial 
viruses, 
une library which consists of phage 
displayin
inding phage can be eluted from the antigen, either with a 
pH shoc
Phage display and selection for stability 
To select the VHH with the desired prop
known as bacteriophage, to select antigen specific antibody fragments (in our case 
VHHs). This technology combines the VHH displayed on bacteriophage particles to the 
DNA encoding this VHH, which is present in the phage. One of the strengths of this 
method is this coupling of phenotype to genotype.  
Collections of these VHH displaying phage are called a library. There are two kind 
of libraries which are commonly used. The imm
g VHHs derived from llamas or camels that were immunized with a certain 
antigen or pool of antigens (Van der Linden, 2000). The second library often used is the 
naïve library which consists of phage displaying VHHs isolated from a non-immunized, 
naïve, llama or camel (de Haard, 1999). A small amount of blood from these animals is 
used to isolate RNA, which is used as a template for reverse transciptase PCR to generate 
cDNA (see figure 4). From this cDNA the genes encoding the VHHs are amplified with 
specific primers. After restriction of the DNA encoding the VHH, this DNA can be cloned 
in a phagemid vector. Bacteria are transformed with these phagemid vectors containing the 
VHHs fused to the minor capsid protein gene III of the phage. The bacteria are used to 
produce phage displaying a wide variety of VHHs, normally 107 or more, all coupled to 
their respective DNA (see figure 4). One of the methods to select phage displaying the 
desired VHH from a large library is called biopanning (see figure 5). The VHHs displayed 
on the phages are allowed to bind to the antigen, which is attached to a solid surface. The 
antigen can also be captured to the solid surface by an (conventional) antibody binding the 
antigen or a tag on the antigen. 
The phage with a VHH specific for the antigen binds and the remaining phage are 
thoroughly washed away. The b
k or by specific elution with a competitor. This results in a pool of phage enriched 
for VHHs binding specifically to the antigen. 
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Figure 4 
Schematic 
representation of 
the construction 
of a phage 
library.  
 
 
 
  
These phage can be used to reinfect bacteria, which allows propagation of the 
DNA encoding the selected VHH and analysis of monoclonal VHHs. Consecutive rounds 
of biopanning can be performed to further enrich the phage pool. The amplification of the 
DNA by PCR resulting in a large, highly diverse pool of VHHs, combined with the easy 
selection via biopanning is another strength of phage display. One round of selection can be 
enough to select specific binders to a wide range of antigens out of a pool of 107 different 
VHHs. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 
Schematic 
representation of 
biopanning.  
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A screening of the selected VHHs should be performed following biopanning, to 
investigate whether the selected VHHs meet the criteria set for the application in which 
they should be used. Usually, a simple high throughput ELISA binding assay is used for the 
primary screening of the VHHs for specific binding to the antigen. This primary screening 
has to be followed by a screening adapted to the application in mind. 
The criteria which should be met by the VHHs are different for every application. 
High production levels and easy purification for cheap production, high stability in a wide 
range of non-physiological conditions, and specific, high affinity binding are just a few of 
these criteria. Together with the increasing number of applications in which antibody 
fragments play a key role this demands high flexibility in the method of selection of these 
antibodies.  
Applied phage display allows for this flexibility. The only essential difference 
from the normal phage display procedure is that binding of the VHHs occurs in the 
presence of the application condition. Phage display performed in the presence of high 
concentrations of shampoo was shown to select for VHHs binding specifically to the 
antigen in shampoo (Dolk, in preparation). This could be a useful tool for circumventing 
laborious protein engineering after selection, when functionality under harsh conditions is 
required. 
 
Outline of this thesis 
The work presented in this thesis focuses on the possibilities of using llama heavy 
chain antibody fragments under extreme conditions. The high stability of VHHs make them 
unique binding blocks with a large potential for use in various applications. 
The ability of reversible folding is a rather unique property of VHHs. Chapter two 
elaborates on the mechanism behind this reversible folding. We describe that VHHs which 
are unfolded at 80°C, are still able to form an antibody-antigen complex. The complex 
formation at 80°C implies that binding and refolding must have taken place at 80°C, 
induced by the antigen.  
Another harsh condition for proteins are high concentrations of non- and anionic 
surfactants present shampoos. VHHs against Malassezia furfur were selected in an attempt 
to inhibit dandruff formation. The application of these VHHs requires storage in high 
concentrations of shampoo and functionality in diluted shampoo. Chapter three describes 
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the attempts to select VHHs functional in shampoo. Phage display performed in the 
presence of shampoo resulted in VHHs binding in shampoo. The higher stability of these 
VHHs was further investigated on structural changes resulting in this higher stability. 
The use of antibodies for the inhibition of viruses is not a new concept. However, 
cost effective antibody treatment to prevent viral infection with conventional antibodies is 
not feasible. Reports have shown that low pH and digestion of antibodies by proteases 
significantly decrease the functionality of orally administered antibodies (Petschow, 1994). 
VHHs inhibiting rotavirus have been selected at low pH and in the presence of pepsin (Van 
der Vaart, in preparation). Chapter four describes the improvement of one good candidate 
VHH by protein engineering. This resulted in a mutant with decreased trypsin 
susceptibility, higher thermostability, higher production levels and equal affinity, which 
could be an economically feasible product for the prevention of rotavirus in developing 
countries. 
Chapter five reviews the three mutational studies performed in chapter two, three 
and four. Surprisingly, these three unrelated studies revealed that mutations in the “former” 
VH-VL interface of the VHH, resulted in an effect on stability. Chapter five describes the 
differences between residues in VHs and VHHs in this area, and speculates on an important 
role for these residues in stability. 
Chapter six describes the results of this thesis in a broader perspective. Emphasis 
is on the stability of VHHs and their adaptation to the single domain status.  
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Abstract 
 
In a previous study we have shown that llama VHH antibody fragments are able to 
bind their antigen after a heat shock of  90°C, in contrast to the murine monoclonal 
antibodies. However, the molecular mechanism by which antibody:antigen interaction 
occurs under these extreme conditions remains unclear. To examine in more detail the 
structural and kinetic aspects of the binding mechanism, an extensive CD, ITC and NMR 
study was initiated. In this study the interaction between the llama VHH -R2 fragment and 
its antigen, the dye Reactive Red-6 (RR6) has been explored. The data show clearly that 
most of the VHH-R2 population at 80 °C is in an unfolded conformation. In contrast, CD 
spectra representing the complex between VHH-R2 and the dye remained the same up to 80 
°C. Interestingly, addition of the dye to the denatured VHH-R2 at 80 °C yielded the 
spectrum of the native complex. These results suggest an induced refolding of denatured 
VHH-R2 by its antigen under these extreme conditions. This induced refolding showed 
some similarities with the well established ‘induced fit’ mechanism of antibody-antigen 
interactions at ambient temperature. However, the main difference with the ‘induced fit’ 
mechanism is that at the start of the addition of the antigen most of the VHH molecules are 
in an unfolded conformation. The refolding capability under these extreme conditions and 
the stable complex formation make VHHs useful in a wide variety of applications. 
Introduction 
 
Antibody-antigen interaction has been well described in recent years. On complex 
formation, conformational changes of antibody and/or antigen can occur. Koshland , first 
described conformational changes that induced an active state in an enzyme, subtilisin, by a 
substrate molecule; this mechanism was called ‘induced fit’ (Neet and Koshland 1966). 
This mechanism can be described as fast bimolecular association followed by a 
unimolecular isomerisation. Meanwhile, examples of this ‘induced fit’ mechanism have 
been described for both antibody-antigen interaction as well as other protein-protein 
interactions and protein-DNA interactions (Webster, 1994; McEwan, 1996; Burley, 1994). 
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The equilibrium between the complex and the uncomplexed antigen and antibody 
fragment is described by a simple model, the law of mass action. The equilibrium will set 
when the rate at which new antibody-antigen complexes are formed equals the rate at which 
the antibody-antigen complexes dissociate. However, whether the equilibrium is directed 
towards the complex or the dissociated antibody and antigen depends on a lot of factors, 
like the temperature. Extreme conditions necessary for a lot of applications in research or 
the industry can shift this equilibrium in such a way that the antibodies are not useful any 
more. 
A novel class of IgG antibodies was discovered in camelids by Hamers-Casterman 
and co-workers, (1993). These antibodies are devoid of light chains and are referred to as 
heavy chain antibodies. The binding part of the heavy chain antibodies comprises only a 
single domain, called VHH. Camelid VHH’s display similar functional characteristics with 
respect to specificity and affinity as compared to classical antibodies (Van der Linden, 
1999; Muyldermans, 2001). We have shown that the llama VHH antibody fragments can be 
produced at high levels in Saccharomyces cerevisiae, up to 2.5 mg l-1 OD660-1 in shake flask 
or ten-fold higher with fed-batch fermentation at 10 L scale (Frenken, 1998; Frenken, 2000; 
Thomassen, 2002). A remarkable difference between the llama antibody fragments and the 
convential antibody fragments is the apparently higher heat stability of the llama VHH’s 
(Van der Linden, 1999). Van der Linden showed that some of the VHH fragments were 
able to bind their antigen even at a temperature as high as 90 °C. Other fragments were 
found not able to bind their antigens at this temperature, but could bind their antigen upon 
cooling down. We have shown that one of these llama VHH antibody fragments against the 
human pregnancy hormone hCG is indeed able to refold into its native conformation after 
exposure to high temperatures (Pérez, 2001), in contrast to conventional antibodies which 
tend to aggregate. This results in a higher intrinsic stability of VHHs (Ewert, 2002; 
Conrath, 2003). The question arose whether the VHH antibody fragments which can bind 
their antigen at high temperatures still have their native structure or whether refolding of 
the antibody takes place induced by addition of the antigen. 
In order to obtain more insight into the mechanism of binding at these extreme 
temperatures, we have used the VHH fragment R2, which binds specifically to the copper 
containing azo-dye RR6 (Van der Linden, 2000). This chemical antigen, the azo-dye RR6, 
has the advantage that it is not altered by the extreme conditions used in these experiments. 
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CD spectroscopy was used to determine if the VHH-R2 fragment was completely unfolded 
at high temperatures and whether addition of the antigen at high temperatures could induce 
complex formation of the VHH-R2 fragment and its antigen. Other antibody fragments and 
different antigens were used to determine if this mechanism was generic or specific for 
VHH-R2. NMR spectroscopy was used to obtain more detailed information on the structure 
of VHH-R2 during unfolding, binding and refolding. Isothermal titration calorimetry was 
used to investigate the kinetic aspects of the interaction between VHH-R2 and the dye. 
We have found that the majority of the population of VHH-R2 molecules is 
unfolded at 80 °C. However, the preformed complex of VHH-R2 and the dye is not 
affected by the increase in temperature. Surprisingly, addition of the antigen at 80 °C was 
able to refold VHH-R2 to its native conformation.  
The remarkable refolding properties of VHH domains and the stability of the 
complex make them very suitable for various applications. For instance, we have shown 
that they can be used over 2000 times in affinity purification without any measurable loss 
of binding capability (Verheesen, 2003). But also for applications in protein arrays they 
proved to be very suitable (Zhu, 2000). On one hand they can make very stable complexes 
with their antigen with binding properties exceeding traditional antibodies, on the other 
hand the chemically modification necessary to link them on a support does not alter their 
binding properties. 
Material and methods 
 
Fragments used in this study 
The fragments used in this study are the binding domains of Llama heavy chain 
antibodies (VHH). VHH-R2 against the azo-dye RR6, VHH-A52 against the azo-dye RR1, 
and VHH-H14 against the human pregnancy hormone hCG were used in this study. The 
isolation of VHH’s against the azo-dye RR6, the azo-dye RR120 (dimer of RR1) and the 
human pregnancy hormone (hCG) has been described elsewhere (Spinelli, 1996; Frenken, 
2000). The VHH’s were produced in Saccharomyces cerevisiae via batch fermentation 
(Van der Linden, 2000). VHH’s were purified using a 5 ml ProteinA column (Hi-Trap, 
Pharmacia). Uniformly 15N-labelled VHH-R2 was produced by using 15N-labelled 
ammonium sulphate as the sole nitrogen source. The affinities of the antibodies were in the 
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nanomolar range (Van der Linden, 1999). VHH-R2, kon = 1.54 x 105 M-1 s-1; koff = 3.34 x 
10-3 s-1; KD = 22.0 nm. 
 
Circular dichroism 
CD spectra were collected using a thermostated (20-80 ˚C) Jobin-Yvon CD6 
Dichrograph Circular Dichroïsm spectrophotometer. The data were processed with the 
Dichrograph software version 1.3. Experiments in the near ultra violet region (250-350 nm) 
were performed with 37 µM antibody fragment in PBS pH 7.4 in 10 mm cylindrical quartz 
cuvettes (Helma). The reactive chloride groups of the azo-dye RR6 were blocked in 1M 
NH4Cl. After blocking, the RR6 was transferred to PBS buffer pH 7.4. The spectral 
bandwidth was automatically kept at 2 nm. The wavelength increment was 0.2 nm/step and 
the accumulation time was 1 s/ step. Each spectrum resulted from averaging five successive 
scans. The spectra of the solvent alone and solvent with RR6 or RR1 were recorded under 
identical conditions and were subtracted from the protein spectra. 
Experiments in the far ultra violet region (190-250 nm) were performed with 90 
µM peptide in ddH2O in 2 mm quartz cuvettes (Helma). The reactive chloride groups of the 
azo-dye RR6 were blocked in 1M NH4Cl. After blocking, the RR6 was transferred to PBS 
buffer pH 7.4. Each spectrum resulted from averaging five successive scans. The spectra of 
the solvent alone and solvent with RR6 were recorded under identical conditions and were 
subtracted from the peptide spectra. 
 
NMR 
For the NMR measurements, uniformly 15N-labelled VHH-R2 samples were 
prepared in a buffer containing 10 mM deuterated sodium acetate (99.5% D) pH 4.6, and 
100 mM NaCl. The protein concentration was 0.1 mM and the samples contained 90% H2O 
and 10% D2O (99.9% D). All NMR data sets were collected on a Bruker 600 MHz DMX 
spectrometer equipped with a 5 mm inverse triple-resonance probehead (1H/15N/13C) with 
a self-shielded z-gradient coil and a variable temperature unit. [15N,1H] water flip-back 
HSQC (HSQC) spectra were measured (Mori, 1995). The spectral width and number of 
complex points in the 15N dimension was 1672 Hz (folding-in some backbone resonances) 
and 128 respectively and 9259 Hz and 2048 in the 1H dimension. Quadrature detection in 
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the indirectly detected dimensions was accomplished using the States-TPPI acquisition 
method (Marion, 1989). NMR data were processed using XWINNMR software from 
Bruker. All dimensions were apodised using shifted sine-bell windows and zero-filled to 
the next power of two to improve the digital resolution. 
 
Isothermal titration calorimetry 
ITC was performed using a Microcal Omega titration microcalorimeter (Microcal, 
Inc.) connected to an external waterbath. All measurements were performed using samples 
which were degassed just before use. To investigate the binding of RR6 to VHH-R2 
experiments were performed with 33 µM antibody fragment in PBS pH 7.4 in the cell and 
0.875 mM blocked RR6 in PBS buffer pH 7.4 in the syringe. Cell volume was 1,345 ml of 
VHH-R2. Fifty injections of 6µl of RR6 were performed. The solution was stirred at 700 
rpm. In all cases, injections were carried out over a 15 s period with a 4 min equilibration 
period between each injection, which was sufficient for the baseline to be re-established. 
Data analysis was performed using the ITC data analysis software Microcal origin 
(Microcal, Inc.). 
Results and Discussion 
 
CD spectroscopy 
In order to collect information on the tertiary structure of the VHH antibody 
fragments, CD spectra were taken in the near UV area (250-350 nm) at different 
temperatures. Figure 1a shows the CD spectrum of VHH-R2 at 20 °C, which is considered 
to be the native state. The clear negative peaks shown in this spectrum at 281, 290 and 297 
nm represent the CD bands of the aromatic residues present in the VHH-R2 molecule (line 
1), in particular the stacking interactions of the chromophor side chains of the tryptophane 
molecules. Subsequent incubation of the VHH-R2 sample at 70 °C for 120 minutes does 
not affect the CD spectrum (data not shown), indicating that the structure of the fragment 
remains unchanged. However, incubating the VHH-R2 at 80 °C for 10  
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Figure 1 A) CD spectra in the near 
UV area (250 –350 nm) of VHH-
R2 at 20 °C (line 1), 80 °C (line 2) 
and after cooling down to 20 °C 
(line 3). B) CD spectra in the near 
UV area (250 –350 nm) of the 
VHH-R2:RR6 complex at 20 °C 
(line 1), 80 °C (line 2) and after 
cooling down to 20 °C (line 3). C) 
CD spectra in the near UV area 
(250 –350 nm) of VHH-R2 at 80 
°C (line 1), of the VHH-R2:RR6 
complex at 20 °C (line 2) and of 
VHH-R2 at 80 °C after addition of 
a 1:1 molar ratio of preheated RR6 
(line 3). 
 
 
 
 
minutes dramatically alters the CD spectrum of VHH-R2, resulting in the disappearance of 
the CD bands (line 2).  
The hydrophobic stacking interactions between the chromophor side chains are disturbed, 
indicating an unfolded conformation of the fragment. Subsequent cooling of the VHH-R2 
sample back to 20 °C rendered the native spectrum (line 3). This indicates that heat induced 
unfolding of VHH-R2 is reversible, comparable to VHH-H14 11. Figure 1b shows the CD 
spectra of the VHH R2-RR6 complex (line 1). The complex was formed by addition of the 
dye RR6 to a 1:1 molar ratio at 20 °C. The CD spectrum of VHH-R2 with RR6 is different 
from the CD spectrum of VHH-R2 alone.  
 32
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The strong CD bands are probably due to stacking interactions of the aromatic side 
chains, i.e.Trp52A in CDR2 of VHH-R2 is stacked against the naphtyl moiety of the azo-
dye RR6 as shown in the X-ray–structure of the complex 18. No signals have been observed 
in the CD spectrum of the hapten dye RR6 in PBS. Heating the VHH-R2-RR6 complex to 
80 °C did not change the CD spectra (line 2), even after incubation for 1 hour at 80 °C. 
Subsequent cooling down of the complex does not alter the spectrum (line 3). This indicates 
that the complex retains its native conformation at this temperature. The complex of VHH-
R2 with its antigen RR6 is more stable than VHH-R2 alone at high temperatures. 
To obtain more insight into the stability of the complex at high temperatures, the 
VHH-R2 was heated to 80 °C and after equilibration for 5 minutes, the antigen RR6 was 
added to the unfolded VHH-R2. Figure 1c shows the CD spectrum of the unfolded VHH-
R2 at 80 °C (line 1). Subsequent addition of a 1:1 molar ratio of preheated RR6 to the 
antibody at 80 °C resulted in the CD spectrum shown in figure 1c (line 3). Surprisingly, this 
spectrum shows all the characteristics of the spectrum of the antibody-antigen complex 
formed at 20 °C (line 2). This indicates that at 80 °C the VHH-R2-RR6 complex adopts the 
same conformation as the complex formed at 20 °C. 
Control experiments were performed regarding antigen specificity, antibody 
specificity and the effect of the copper in the dye on the CD spectra. To investigate whether 
the refolding was antigen specific, experiments were performed with VHH-R2 and the azo-
dye RR1. The molecular structure of RR1 is different from RR6 and it does not contain  
copper like RR6 (figure 2).   
ELISA experiments at room temperature showed crossreactivity of VHH-R2 with 
RR1 (data not shown). The CD spectrum of VHH-R2 after addition of the dye RR1 was 
different from the CD spectrum of VHH-R2 alone and also different from the CD spectrum 
of the VHH-R2 – RR6 complex.  
This indicates that VHH-R2 is able to form a complex with RR1. However, 
addition of RR1 to the unfolded VHH-R2 at 80 °C does not lead to the native complex of 
R2:RR1 (data not shown). 
To ensure that the refolding of the VHH-R2 was not due to an aspecific interaction 
with RR6, the RR6 azo-dye was added to a different llama VHH fragment, VHH -H14 
raised against hCG.  
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Figure 3a shows the CD spectrum of H14 
alone at 20 °C (line 1). Addition of RR6 did 
not alter the spectrum, indicating that the 
VHH–H14 does not interact with RR6 (line 
2). Accordingly, at 80 °C the VHH-H14 is 
completely unfolded (line 3) and addition of 
the RR6 at 80 °C did not alter the spectrum 
as well (line 4). To exclude that the copper 
alone has an effect on the CD spectrum of 
VHH-R2, CD experiments were performed 
with VHH-R2 in the presence of CuCl2 and 
CuSO4. Addition of CuCl2 or CuSO4 to 
VHH-R2 at 20 °C did not change the spectra  Figure 2. Structure of the copper  
of VHH-R2 This  indicates that the copper is  containing azo-dye RR6 (A) and the azo 
not  responsible  for  the  large  bands  in  the dye RR1 (B). 
CD spectrum  of  VHH-R2  (data not shown). 
A different llama antibody fragment, VHH-A52 raised against the azo dye RR1, 
was used to determine whether the refolding at high temperatures was specific for VHH-R2 
and RR6 or if it is a more generic process. The same set of experiments as with VHH-R2 
was performed. Figure 3b shows the spectra of VHH-A52 (line 1) and the complex of 
VHH-A52:RR1 at 20 °C (line 3). Heating the VHH-A52 to 80 °C showed that the majority 
of the VHH -A52 pool is in an unfolded conformation (line 2). Addition of RR1 to the 
unfolded VHH-A52 at 80 °C led to complex formation and rendered a spectrum identical to 
the native complex spectrum at 20 °C (line 4). This clearly indicates that VHH-A52 is 
capable of refolding upon addition of its antigen at 80 °C just like VHH-R2 with its antigen 
RR6. Addition of RR6 at 20 °C and 80 °C to VHH-A52 also did not alter the spectra of 
VHH-A52 (data not shown). These observations indicate that refolding at 80 °C upon 
addition of the antigen was not specific for VHH-R2, but could be generic for the llama 
antibody fragments. 
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Figure 3 A) CD spectra in the near 
UV area (250 –350 nm) of VHH-
H14 at 20 °C (line 1), with RR6 at 
20 °C (line 2), at 80 °C (line 3) and 
with RR6 at 80 °C (line 4). B) CD 
spectra in the near UV area (250 –
350 nm) of VHH-A52 at 20 °C (line 
1), at 80 °C (line 2), of the VHH-
A52:RR1 complex at 20 °C (line 3) 
and of VHH-A52 at 80 °C after 
addition of a 1:1 molar ratio of 
preheated RR1 (line 4). 
 
 
 
 
Peptide binding 
In order to investigate whether an interaction between denatured VHH-R2 and 
RR6 is possible, a peptide was synthesized comprising the CDR3 binding loop of VHH-R2. 
Figure 4 shows the CD spectrum of the peptide (line1). The spectrum of the peptide  
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Figure 4 CD spectra in the far UV 
area (190-250nm) of the CDR3 
peptide without RR6 (line 1), after 
addition of a 1:1 molar ratio of 
RR6 (line 2), and after addition of 
a 1:3 molar ratio of RR6 (line 3). 
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indicates that the CDR3 peptide is largely in an unordered random coil formation. Addition 
of antigen RR6 to the peptide renders a spectrum as shown in figure 4. This shows that 
there is an interaction between RR6 and the peptide. The spectra with dye shows a shift in 
the 190-210 nm range, which indicates that the antigen RR6 induced a more structured 
conformation of the peptide. All spectra shown are corrected for the spectrum of the buffer 
or buffer with the corresponding concentration of RR6. Therefore the shift of the curve can 
not be an effect of pH. These results indicate that the antigen RR6 is able to interact with 
the unordered CDR3 peptide. 
 
NMR 
To obtain more details on the structure of VHH-R2 upon binding of the dye RR6, 
NMR experiments were performed. HSQC spectra provide information on the chemical 
shift of the amide resonances in the backbone of R2. A well-dispersed amide cross-peak 
pattern is representative for a native protein. Figure 5a shows the superimposed HSQC 
spectra of free 15N-VHH-R2 (red) and the 15N-VHH-R2:RR6 complex (black) at 27 °C. 
Both spectra clearly show that 15N-VHH-R2 and its complex sample is folded. Moreover, a 
few cross-peaks in the spectrum of the 15N-VHH-R2:RR6 complex were shifted and some 
of them were even undetectable. This indicates that these resonances probably correspond 
to the residues in close proximity to RR6 or to residues which undergo long range 
conformational changes upon binding of RR6. The reason that some of the cross-peaks are 
undetectable is due to line-broadening induced by the interaction of the resonating nuclei 
with the unpaired electron of the paramagnetic copper center in RR6. The relaxation of the 
protons in close proximity to the paramagnetic centeris fast and leads to moderately/largely 
broadened signals beyond detection limit. The chemical shift assignments for most of the 
perturbed residues have been obtained and are assigned in figure 5a (the assignments were 
kindly provided by Herve Darbon). The broadened cross-peaks in the spectrum are L20, 
T28, S29, G30, R45, W52a, S62, A94, and V111. In the X-ray structure W52a is in 
stacking contact with the naphtyl moiety of RR6 and is therefore undetectable in the HSQC 
experiment of the complex (Spinelli, 2000). Unfortunately, the NMR resonance 
assignments of the coordinating ligand of the copper, H31a and H31c, are still missing. A 
few other residues in CDR1 close to the histidines co-ordinating the copper i.e. T28, S29  
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Figure 5 A) Superposition of the HSQC 
experiments of 0.1 mM VHH-R2 (red) and VHH-
R2:RR6 complex (black) with the assignments of 
the shifted and broadened amide resonances. B) 
Superposition of the HSQC experiments of the 
VHH-R2:RR6 complex at three different 
temperatures: 27 °C (black), 50 °C (red) and 80 °C 
(blue). 
 
 
 
 
 
 
 
 
 
 
Figure 6 A) Superposition of the HSQC experiments of 
0.1 mM VHH-R2 (black) at 80 °C and after the addition 
of 0.1 mM RR6 at the same temperature (red). B) HSQC 
spectrum of the VHH-R2:RR6 complex heated to 80 °C 
(black) superimposed with the spectrum of the complex 
prepared at 80 °C (red). 
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and G30 were also severely broadened in the complex. The rest of the undetectable residues 
with the exception of L20 were either part of or are close to the CDR's. The 15N-VHH-
R2:RR6 complex was heated from 27 °C to 80 °C (Fig. 5b). The dispersion of the amide 
resonances remained roughly the same up to 80°C except for a small shift of the peaks not 
representative of large conformational changes.  
 However, the intensity of the cross-peaks dropped substantially at higher 
temperatures due to line broadening which could be indicative of aggregation. In contrast, 
when free 15N-VHH-R2 is heated to 80 °C a large shift of the amide resonances to random 
coil chemical shift values has been observed (Fig. 6a). 
This suggests that the majority of the population of the 15N-VHH-R2 molecules is 
unfolded at 80 °C. Addition of an equivalent molar amount of RR6 to denatured 15N-VHH-
R2 at 80 °C rendered a dramatically altered spectrum (Fig. 6a). Remarkably, this spectrum 
appeared to be identical to that from the 15N-VHH-R2:RR6 complex prepared at 27 °C and 
subsequently heated to 80 °C (Fig. 6b).  
This finding gives direct evidence for the refolding of non-native 15N-VHH-R2 at 
80 °C upon binding of its antigen RR6. The NMR experiments were performed at pH 4.6 to 
minimise the exchange of amide protons. Deviations because of differences in pH between 
the CD and NMR experiments were checked by repeating the CD experiments at pH 4.6, no 
differences were observed. The NMR data confirms the CD data and gives direct evidence 
for the hypothesis of ‘induced refolding’. 
 
Isothermal Titration Calorimetry 
To understand the kinetics involved in the refolding process isothermal titration 
calorimetry (ITC) was performed. Small amounts of RR6 were titrated to VHH-R2 at 20 °C 
and 80 °C. Figure 7a shows a typical binding isotherm of RR6 to VHH-R2 at 20 °C.  
The measured heat change for each injection is negative up to a molar ratio of 3 , 
after which it remains constant up to 7 equivalents of RR6. The exothermic signals of –8 
kcal/mol at molar ratios up to 3 represent the heat change of complex formation of RR6 to 
VHH-R2. The enthalpic signals at molar ratios between 3 and 7 represent the heat of 
dilution of the RR6 and are observed in a control titration, wherein RR6 was titrated to PBS 
buffer only. Figure 7b shows the binding isotherm at 80 °C. The measured heat change for  
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Figure 7 A) Binding isotherm of the titration of RR6 
to VHH-R2 at 20 °C. Top panels are the raw ITC 
data. Lower panels are the integrated calorimetric 
heats. B) Binding isotherm of the titration of RR6 to 
VHH-R2 at 80 °C. Top panels are the raw ITC data. 
Lower panels are the integrated calorimetric heats. 
 
 
 
each injection is negative up to a molar ratio of 
1.5 , after which it remains constant up to 7.0 
equivalents of RR6. The exothermic signals of –
39 kcal/mol represent the complex formation of 
RR6 to VHH-R2 and the refolding of VHH-
R2.Values for the enthalpy change and the 
number of binding sites (N) correspond to the 
intercepts and midpoints, respectively, of the 
titration curves and can be obtained directly 
from the ITC data. Both curves were fitted with 
a model assuming two binding events, because 
two RR6 molecules were shown to bind to 
VHH-R2 (Spinelli, 2000) (see table 1).  
The binding isotherms of the titration of RR6 to VHH-R2 at 20 °C and 80 °C 
shows that titration of RR6 is exothermic at both temperatures. The observed enthalpy 
change indicates that refolding takes place at 80 °C and confirms the CD data. At 20°C the 
kinetic parameters of the binding of the first and the second RR6 molecule are almost 
identical. At 80°C the kinetic parameters of the binding of the first RR6 molecule are 
comparable to the parameters at 20°C, although the association constant is slightly lower. 
However, the kinetic parameters of association of the second RR6 molecule are drastically 
different, suggesting that at 80°C the second  RR6 molecule is not able to bind efficiently. 
The data obtained from the crystal structure of the complex show two binding sites for  
 39 
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 N1 Ka 1  
(M-1) 
∆H1  
(J/mol) 
∆S1 
(J/mol/K) 
N2 Ka 2  
(M-1) 
∆H2  
(J/mol) 
∆S2 
(J/mol/K ) 
RR6 to R2 
at 20°C 
1.4 3.4x106 -7400 4.6 1.6 4.6x107 -8446 6.3 
RR6 to R2 
at 80°C 
1.4 1.9x106 -3.9x104 -83 6.1* 350.2* 1.7x106 * 503* 
 
Table 1. The calorimetric data corresponding to the RR6 titrations at 20°C and 80°C fitted using a 
model assuming two binding events. The asterix indicates that the accuracy of these results are very 
poor. 
 
RR6, however the RR6 monomer was the authentic hapten and our model is based on 
binding of a monomer RR6 by VHH-R2. The large enthalpic change of -35 kcal/mol at 80 
°C can be explained because not only binding and complex formation, like at 20 °C, but 
also refolding occurs. The ITC data confirm the CD data and show that the kinetic 
parameters of binding at 80°C is remarkably comparable to binding at 20°C. 
Conclusions 
 
We have shown by CD spectroscopy and NMR that unfolded VHH-R2 was able to 
form a native complex after addition of its antigen RR6 at high temperature, indicative of 
refolding of VHH-R2 at 80 °C. Figure 8 shows a scheme of the possible steps in the 
binding process of a VHH to its antigen at 80 °C. A possible explanation for complex 
formation at these high temperatures is that the small fraction of native VHH-R2 at 80°C is 
able to form a complex with the dye RR6.  
 
 
 
 
 
 
 
 
 
Figure 8. A reaction scheme of native and unfolded VHH and its antigen towards complex formation 
with two suggestions for the role of addition of antigen in induced refolding at high temperature. 
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Consequently, the equilibrium will set, according to the law of mass action, 
leading to a new equilibrium with the majority of the VHH-R2 in complex with RR6. 
Another explanation for complex formation could be that the antigen first binds to unfolded 
VHH-R2, which subsequently induces the refolding process. Figure 4 in this paper shows 
that an interaction between the unordered CDR3 peptide and the dye RR6 is possible. This 
can be explained in more detail after careful inspection of the X-ray structure. The X-ray 
data showed a dimer of RR6 bound to the VHH , however only one RR6 molecule of the 
dimer is buried in a cavity at the surface of the VHH (Spinelli, 2000). This first half of the 
dimer is buried for 60% in the VHH , embedded between the three CDRs. Binding of a RR6 
molecule to CDR3 increases the probability that the RR6 molecule binds to a second CDR, 
resulting in formation of the cavity as present in the native VHH-R2.  
RR6 was shown to induce structural changes in the unstructured CDR3 peptide. 
These structural changes in unfolded VHH-R2 could increase the probability of reformation 
of the loops of the CDRs. This could be the folding nuclei that allows long range interacting 
residues to come in more proximity of each other and refold to the correct native 
conformation, thereby trapping the unfolded VHH-R2 into a stable conformation, the VHH-
R2:RR6 complex . In this case the antigen RR6 would act like a small chaperone molecule, 
which acts by increasing the probability of unfolded proteins to form a stable structure 
(Hendrick and Hartl, 1995; Ellis and Hartl, 1999; Torok, 2001). However, the difference is 
that small chaperone molecules often bind to regions that are buried in the native protein, 
but exposed in the unfolded protein, whereas RR6 binds to the CDRs that are also exposed 
in the folded VHHs. The main difference between these two pathways is whether RR6 
binds to the unfolded VHH-R2 or to the native VHH-R2 at 80 °C. In this perspective, it was 
interesting to see that the azo-dye RR1 did crossreact with native VHH-R2 to some extent 
at 20 °C. However, addition of RR1 to the unfolded VHH-R2 at 80 °C did not induce 
refolding of VHH-R2. The interaction of RR1 with VHH-R2 is probably not sufficient to 
induce refolding. Comparing the molecular structures of RR1 and RR6, there are some 
remarkable resemblances, the aromatic rings, the three sulphonate groups and the sulfonyl-
phenol group. Inspection of the contacts of VHH-R2 with RR6 shows that CDR1 is in 
contact with RR6 via the copper molecule, CDR2 is in contact with the three sulphonate 
groups of RR6 and CDR3 with the p-sulfonyl-phenol group of RR6 (figure 9). RR1 does 
not contain a copper, the sulphonate groups of RR1 are differently orientated compared  
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Figure 9. The combining site of the anti-RR6-VHH and the RR6 inside, viewed from the top. A) 
Water-accessible surface of the VHH displaying the cavities, with the bound RR6 molecule (red) in 
ball-and-stick representation, with the copper ions as silvery blue spheres. The green colour identifies 
the protruding surfaces, and the gray colour identifies the reentring surfaces (GRASP representation, 
32). The localisation of the three CDRs has been indicated by H1, H2, and H3. B) Stereoview of the 
P1 and N1 groups of the P1+N1 groups of the RR6 molecule in complex with the 3 CDRs of the anti-
RR6-VHH fragment. The CDRs 1-3 are red, green, and blue, respectively. (Reproduced with 
permission from Biochem. 2000, 39(6), 1217-1222. Copyright 2000 Am. Chem. Soc.) 
 
 
to RR6, and thus it is likely that the contact of RR1 to VHH-R2 is with the identical p-
sulfonyl-phenol group of RR1 to CDR3 of VHH-R2. The reason why RR1 is not able to 
induce refolding by long range interactions could be that stabilisation of the CDR loop(s) 
followed by refolding is not efficient with the antigen RR1.  
VHH-A52, a VHH selected against and binding specifically to the azo dye RR1, 
did show refolding after addition of RR1 at 80 °C. In this case the interaction of RR1 with 
VHH-A52 is sufficient to induce refolding. RR1 is not only able to bind to VHH-A52, but 
is also capable of inducing long range interactions in VHH-A52 necessary to refold VHH-
A52 to its correct native conformation. Spinelli reported the structure of VHH-A52 with 
RR1 (Spinelli, 2001). Where VHH-R2 forms a cavity with its three CDRs and binds RR6 in 
a central combining site, VHH-A52 binds RR1 on a lateral combining site with CDR2, 
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CDR3 and a framework residue. Thus, although the mechanism for binding their antigen is 
different between VHH-A52 and VHH-R2, both VHHs are able to refold upon addition of 
their antigen at 80 °C. We concluded that refolding at 80 °C upon addition of the antigen is 
not specific for the VHH-R2, but is generic for the llama antibody fragments against 
organic haptens. However, high affinity binding of VHH to its antigen is a necessity to 
enable long range interactions to occur. 
The binding of camelid single domain antibody fragments under extreme 
conditions increases the possibilities to use these simple binding molecules in a wide range 
of applications. They are not only suitable for applications where a relatively short rise in 
temperature is necessary like with sterilization, but they may also be used in application at 
higher temperature or under different denaturating conditions. Because of the single domain 
‘induced refolding’ is a unique characteristic of llama antibody fragments in general. 
This paper shows that the increased stability reported in a lot of articles concerning 
single domain antibodies derived from camelids might be contributed for a large part by 
their reversible folding and capability of binding to their antigen under extreme conditions. 
This was shown by the fact that the unfolded VHH was still functional, that is: able to 
efficiently bind to their antigen to a great extend in a relatively short time span.  
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Abstract 
 
Phage display of llama single domain antibody fragments (VHHs) can select 
VHHs that function well under a wide range of application conditions.  We show here that 
this technique can even be extended to very harsh conditions such as the presence high 
concentrations of shampoo. In the presence of shampoo, containing non- and anionic 
surfactants, we selected several VHHs that all bind the cell wall protein Malf1 of the 
dandruff causing Malassezia furfur. These VHHs show high stability in the presence of 
shampoo, but also under other denaturing conditions, like a high urea concentration. Many 
of the stable VHHs were found to have an arginine at position 44. Introduction of this 
arginine in the most stable VHH that lack this arginine resulted in a  dramatic further of its 
stability. The combination of the unique properties of VHHs with applied phage display, 
and protein engineering, is a powerful method to obtain highly stable VHHs that can be 
used in a wide range of applications.  
Introduction 
 
The human scalp houses a very complex balance between many micro-organisms. 
One of these organisms, Malassezia furfur (M. furfur) is an anthropophilic fungus that 
belongs to the physiological skin flora. This fungus can grow in a yeast phase and in a 
mycelial phase. M. furfur has been implicated in the formation of dandruff (6, 12, 42, 46) 
and other skin diseases, like psoriasis (1). Compared to people without dandruff, 
significantly increased numbers of M. furfur were found on the scalp of those with dandruff 
(36, 43) Reduction of the number of M. furfur cells on persons suffering from dandruff 
resulted in a decrease in the severity of dandruff (34).  
To date, the treatment and/or prevention of dandruff has involved the use of 
chemical anti-fungal compounds (26), compounds such as ketoconazole (35), selenium 
sulfide (6), ciclopirox olamine, piroctone-olamine, zinc pyrithione and sulfur-containing 
substances (42).  
We here demonstrate a fully novel approach to inhibit M. furfur by inhibition with 
antibodies. For successful application of antibodies in consumer goods they must meet 
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certain requirements regarding cost of production, specificity, affinity and especially the 
stability of the antibody under application conditions. 
Camelid heavy chain antibodies have been shown to be a useful tool in many 
biotechnological applications (10, 14, 27, 47). The variable domains of these heavy chain 
antibodies (VHH) form a single binding domain (15). The simple, one domain structure of 
these VHHs give them unique characteristics with respect to production, folding and 
stability (13, 33). Furthermore, camelid VHHs display similar behaviour with respect to 
specificity and affinity as compared to classical antibodies (45). The extra long protruding 
CDR3 of VHHs is implicated in the efficiency of inhibition of enzymes and small 
organisms (7, 8, 10, 22). Therefore VHHs are good candidates for antibody-mediated 
delivery of anti-dandruff agents or even direct neutralization of M. furfur. 
Phage display is a common method for the selection of specific antibody 
fragments under laboratory conditions (18). We describe the selection of VHHs specific for 
the M. furfur cell surface protein (Malf1) via phage display under application conditions, 
which in this case are a high concentration of non- and anionic surfactants  present in 
shampoos, like Andrelon and Organics. 
Surprisingly, phage display can select for VHHs binding specifically to Malf1, 
even under harsh application conditions such as high concentrations of shampoo. In 
addition, it was shown that increasing the selection pressure during phage display selects 
for VHHs with increased stability. Comparison of the sequences of the VHHs selected 
under application conditions with a large number of sequences of VHHs obtained after 
selection for under physiological conditions revealed that an arginine was often observed at 
position 44 in the more stable VHHs. Point mutations of position 44 confirmed the 
importance of a basic amino acid at this position.  
Materials and Methods 
 
Strains and growth media 
The Escherichia coli strain used in this study for phage display and plasmid 
propagation was E. coli TG1. This strain was grown in 2TY medium with 100 µg/ml 
ampicillin and/or 25 µg/ml kanamycin and/or 1% (v/v) glucose when appropriate.  
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VHHs were produced in Saccharomyces cerevisiae VWK18 gal1 (40) as described 
before (44). In short, individual S. cerevisiae colonies were transferred to test tubes 
containing selective minimal medium (comprising 0.7% yeast nitrogen base, 2% glucose, 
supplemented with the essential amino acids and bases) and were grown for 24 h at 30°C. 
Subsequently, the cultures were diluted ten times in YP medium (comprising 1% yeast 
extract, 2% bacto pepton) and 2% glucose and 2% galactose for induction. After 48 h of 
induction with galactose, the cells were harvested. Antibody fragments were purified with a 
ProtA column or with TALON (Clontech) using the HIS-tag. 
The Malassezia furfur extract was obtained from John Whitley from the 
Karolinska hospital in Stockholm, Sweden. Preparation of this extract has been described 
by Zargari et al. (48). The recombinant Malf1 (rMalf1) was produced in Escherichia coli 
JM109-DE3 and purified from inclusion bodies using standard protocols (41). 
 
Induction of a humoral immune response in llama. 
A llama was immunised with extract of Malassezia furfur and recombinant Malf1 
in oil emulsion (1:9 V/V, antigen in PBS : Specol) (2) subcutaneously and intramuscularly. 
Per immunisation round 0.75-1.5 ml water in oil emulsion was injected containing 1 mg M. 
furfur extract or 200 µg recombinant Malf1 protein. The immune response was monitored 
by titration of serum samples in ELISA with rMalf1 immobilised on Nunc maxisorb plates 
(coat solution 5 µg/ml rMalf1 diluted in phosphate buffered saline, 100 µl/well). 
Subsequently, wells were blocked (4 % Marvel in PBS, 400 µl/well) and incubation with 
serum dilutions in  0.15 % Tween 20/PBS. The bound llama antibodies were detected with 
poly-clonal rabbit-anti-llama IgG (R906, ID-DLO) in 0.15 % Tween 20/PBS, 100 µl/well 
(obtained via immunising rabbits with llama immunoglobulins purified via ProtA and 
ProtG columns) and swine-anti-rabbit immunoglobulins (Dako) conjugated to horse radish 
peroxidase (in 0.15 % Tween 20/PBS, 100 µl/well). Finally, the peroxidase enzyme-activity 
was determined with tetramethylbenzidine (TMB) and ureaperoxide (UP) as substrate and, 
after termination of the reaction by adding H2SO4, the optical density was measured at 
450nm .  
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Isolation of VHH fragments  
A blood sample of about 200ml was taken from an immunised llama. An enriched 
lymphocyte population was obtained via centrifugation on a Ficoll (Pharmacia) 
discontinuous gradient. From these cells, total RNA was isolated by acid guanidium 
thiocyanate extraction (5). After first strand cDNA synthesis using MMLV-RT (Gibco-
BRL) and random oligonucleotide primers (Pharmacia), DNA fragments encoding VHH 
fragments and part of the long or short hinge region were amplified by PCR using specific 
primers: VH - 2B: AGGTSMARCTGCAGSAGTCWGG (S = C and G, M = A and C, R = 
A and G, W = A and T), Lam-07: AACAGTTAAGCTTCCGCTTGCGGCCGCGGAG 
CTGGGGTCTTCGCTGTGGTGCG (short hinge), Lam-08: AACAGTTAAGCTTCCGC 
TTGCGGCCGCTGGTTGTGGTTTTGGTGTCTT GGGTT (long hinge). 
The DNA-fragments generated by PCR were digested with PstI (coinciding with 
codon 4 and 5 of the VHH domain, encoding the amino acids L-Q) and BstEII (naturally 
occurring in FR4 region of the majority of the VHH-genes and coinciding with the amino 
acid sequence Q-V-T). The digested PCR-products, with a length between 300 and 400bp 
(encoding the complete VHH domain, but lacking the first and the last three codons), were 
separated by electrophoresis on agarose gels and, after purification from the gel-slices with 
the Qiaex-II extraction kit (Qiagen), cloned (PstI/HindIII) in the phage display vector 
pUR4676. This vector was derived from pHEN1 (17). 
 
Selection of VHHs binding Malf1 
From the isolated RNA of two different bleeds, which were taken after 3 
immunisations with the Malassezia furfur extract and after 6 immunisations with the 
recombinant Malf1 protein phage-display libraries were created. Each library was 
composed of two sub-libraries, one containing DNA fragments derived from short-hinged 
antibody fragments and one derived from long-hinged antibody fragments (28). After phage 
production from each sub-library, phages were isolated and pooled. 
A display library with 107 clones, of which 75% is estimated to contain a complete 
VHH encoding insert (Van der Vaart, personal communication), was constructed in 
phagemid vector pUR4676. Phage particles exposing VHH fragments were prepared by 
infection of E. coli TG1 cells harbouring the phagemid with helper phage VCS-M13 
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(Pharmacia). Free VHHs were removed by precipitation of phage from the culture 
supernatant with PEG6000, thereby avoiding a competition for binding to antigen between 
phage-bound and free VHH domains. The E. coli phage was incubated for one hour in a 
maxisorp tube with immobilised rMalf1. The phage particles complexed to rMalf1 via their 
exposed VHHs were, after 20 washes with PBS, eluted with a pH-shock (0.1 M 
triethylamine). This phage population, which is enriched for Malf1 binders, was rescued by 
infection of E. coli host cells (24). Individual E. coli clones were grown in wells of 
microtiter plates, and the production of VHHs was induced by addition of IPTG (0.1 mM). 
Culture supernatants containing free VHHs were tested in ELISA experiments for binding 
rMalf1 using the myc-TAG for detection. OD450 signals >0.2 (twice above background) 
were considered positive for binding to Malf1. 
 
Selection of VHHs binding Malf1 via phage display under application 
conditions. 
The shampoo stability of Malf1 in the ELISA was tested by incubating the plates 
with various shampoo concentrations. Various concentrations of Andrelon (10%-40%) 
and Organics (2%-20%) were used. After washing, all ELISA plates were still 
immunoreactive.VHH selection under application conditions was performed in 2-40% (v/v) 
Andrelon which will be called shampoo-1 and in 2-20% (v/v) Organics, which will be 
called shampoo-2. The chemical composition of these shampoos is available  as 
supplemental material (at http://www.cmbi.kun.nl/articles_ext/). Dilutions of shampoo were 
made in PBS with 0.1 % (w/v) Marvel and 0.05% (v/v) Tween20. Selections were 
performed as described above. The binding step in the phage display was 1 hour and at 
room temperature. Individual E. coli clones were grown and the production of VHH was 
induced by addition of IPTG (0.1 mM). Culture supernatants containing free VHHs were 
tested in ELISA experiments in 10% shampoo-1, or 2% shampoo-2 for binding rMalf1 
using the myc-TAG for detection. OD450 signals >0.2 were considered positive for binding 
to Malf1. 
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ELISA 
Maxisorp plates were coated overnight with 10 µg rMalf1 in 100µl/well at 4°C. 
Plates were blocked with 200 µl 4% Marvel in PBS. Equal amounts of VHH (3.3 µM) were 
incubated for 1 hour at room temperature in 2% Marvel, 0.05% Tween 20 in PBS or in the 
desired concentration of shampoo-1, shampoo-2, ureum, or guanidine/HCl diluted in PBS, 
0.5% Marvel, 0.05% Tween 20  (100µl/well). After washing with PBS/Tween (0.05%), the 
plates were incubated with poly-clonal rabbit-anti-llama IgG and swine-anti-rabbit 
immunoglobulins (Dako) conjugated to horse radish peroxidase (in 0.05 % Tween 20/PBS, 
100 µl/well). Finally the peroxidase enzyme-activity was determined with 
tetramethylbenzidine and ureaperoxide as substrate. The optical density was measured at 
450nm after termination of the reaction by adding of 50 µl 1M H2SO4. All experiments 
were done at least in duplicate, typical results are shown. 
 
Construction of the mutants 
Mutants of Malf A7 and Malf D12 were created with PCR by ‘splicing by overlap 
extension’ (16). In short, complementary primers, with nucleotides substituted for 
generating Arg44, Lys44, or Glu44 respectively, are used in a two step PCR to generate 
DNA fragments containing the desired mutation. These products were digested with 
restriction enzymes and cloned into the original vector. The correctness of the mutated 
genes was confirmed by sequence analysis. All numbering and CDR definitions according 
to Kabat (19) 
 
Crystallisation conditions 
Crystals were obtained in 10% PEG 6000, 100 mM Hepes (pH 7.3) and 5% MPD 
using the vapor diffusion method. The drop was constituted from 1 µl of protein at 11-15 
mg/ml and 1 ml of reservoir solution. The OE7 crystals pertain to the trigonal space group 
P3221 with unit cell dimensions a=b=71.40 Å, and c=74.84 Å.  They contain a molecule per 
asymmetric unit giving (assuming a molecular mass of 12500 Da) a Vm= 4.4 Å3/Da which 
correspond to a solvent content of 72 % (25). Crystals were cryoprotected with 7% MPD 
and flash frozen to 100 K. 
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Data collection and processing 
The 2.2 Å resolution data were collected on the beamline ID14-EH2 (ESRF, 
Grenoble) using a CCD detector (λ=0.9326 Å). The data were indexed and integrated using 
Denzo (31), scaled using SCALA and structure factors amplitudes were calculated using 
TRUNCATE (4). The data processing statistics to 2.2 Å resolution are given as 
supplemental material in table 1. 
 
Phasing, model building and refinement 
The crystal structure of the lama OE7 fragment was solve with the molecular 
replacement method with the AmoRe program (30) using the lama HC-V fragment (PDB 
code: 1HCV ) as the search model. A solution was obtained giving a correlation coefficient 
of 0.45 and R-factors 40% and the electron density map obtained was readily interpretable. 
Preliminary refinement was performed with CNS (3) against the high (2.2 Å) 
resolution data set using bulk solvent correction and standard CNS protocols. Cycles of 
unrestrained, maximum likelihood refinement, and TLS refinement  using REFMAC (4) 
were alternated with manual inspection of the model using the program Turbo-Frodo (39). 
Final refinement data are summarized in Table 1 at http://www.cmbi.kun.nl/articles_ext/. 
The complete model has a Rwork of 19% and an Rfree of 20.6% (Table 1). The 
stereochemistry was analyzed with Procheck (21) which indicates that 95% residues are in 
the most favorable region and 5% in the additionally allowed region.  
Results 
 
Initial selection of VHHs that can bind Malf1 
The immune response of an immunised llama was followed by titration of serum 
samples in ELISA. The results show an enrichment in antibodies against Malf1 after three 
immunizations. A VHH phage display library with 107 clones was created. After production 
in E. coli, the phages were isolated from the medium. The results of two rounds of phage 
display with selection for Malf1 are shown in table 1. In this stage PBS was used during the 
binding step, and not yet shampoo. The three parallel experiments of the second selection 
step were all done with the output of experiment C of the first step. 
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 Coating Phage titer Enrichment Positives Perc. positives 
First  A: No coating 3.0 x 103 N.A. N.D. N.D. 
round B: 5 µg Malf1 9.3 x 105 310 fold N.D. N.D. 
 C: 50 µg Malf1 6.6 x 106 2200 fold 11/64 17% 
      
Second  C1: No coating 3.0 x 103 N.A. N.D. N.D. 
round C2: 0.5 µg Malf1 1.8 x 108 60.000 fold 4/64 6% 
 C3: 5 µg Malf1 1.5 x 109 500.000 fold 21/64 33% 
Table 1. Phage titers, enrichments, and percentage of binders of the two rounds of selection for Malf1 
binding.  
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in PBS.  Figures 1B and 1C show that only one VH
Nearly two hundred monoclonal VHHs were expressed and the Malf1 binding of 
these fragments was tested in ELISA experiments. The percentage of VHHs capable of 
binding Malf1 was determined (see table 1). Ten of these were selected and tested for 
Malf1 binding under application conditions. Figure 1A shows that they all can bind Malf1 
H can bind Malf1 in shampoo. 
 
 
 
 
 
 
Figure 1 Binding of VHH to Malf1 after 2 
lection rounds. A) binding in PBS, B) se
binding in 10% shampoo-1 C) binding in 
2% shampoo-2. Binding was measured for 
four different dilutions of ten VHHs each. 
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Phage display in shampoo 
Table 2 shows the results of two rounds of phage display with selection for Malf1 
in the presence of shampoo. The first round of selection in shampoo was started with the 
output of experiment C (see table 1). Monoclonal VHHs were expressed and the Malf1 
binding of these VHHs was tested in their respective shampoo (see table 2). Ten positive 
VHHs were picked from F2 and ten from G3.  
 
 Coating Incubation Phage titer Enrichment Perc. positives 
First  D1: No coating 2% Shampoo-2 3.0 x 104 N.A.  
round D2: 5 µg Malf1 2% Shampoo-2 1.0 x 106 30 fold 55% 
shampoo D3: 5 µg Malf1 5% Shampoo-2 6.0 x 104 2 fold  
 D4: 5 µg Malf1 20% Shampoo-2 - None  
 E1: No coating 5% Shampoo-1 7.5 x 104 N.A.  
 E2: 5 µg Malf1 5% Shampoo-1 1.0 x 106 13 fold  
 E3: 5 µg Malf1 10% Shampoo-1 6.7 x 105 10 fold 10% 
 E4: 5 µg Malf1 40% Shampoo-1 7.5 x 104 None  
      
Second  F1: No coating 2% Shampoo-2 3.0 x 103 N.A.  
round F2: 5 µg Malf1 2% Shampoo-2 2.6 x 107 8600 fold 82% 
shampoo F3: 5 µg Malf1 5% Shampoo-2 5.1 x 104 17 fold  
 F4: 5 µg Malf1 20% Shampoo-2 - None  
 G1: No coating 5% Shampoo-1 3.0 x 103 N.A.  
 G2: 5 µg Malf1 5% Shampoo-1 1.2 x 106 400 fold  
 G3: 5 µg Malf1 10% Shampoo-1 1.2 x 106 400 fold 60% 
 G4: 5 µg Malf1 40% Shampoo-1 9.0 x 104 30 fold  
Table 2. Phage titers, enrichments, and percentage of binders of the two rounds of selection for Malf1 
binding in shampoo. 
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different concentrations of the two shampoos. It can be seen that all shampoo-selected 
VHHs bind Malf1 in their respective shampoos and that the one PBS-selected VHH that  
Figure 2. Binding of VHH to Malf1 after 2 selection rounds in shampoo. A) binding of shampoo-2 
selected VHHs in PBS B) binding of shampoo-1 selected VHHs in PBS C) binding of shampoo-2 
selected VHHs in shampoo-2 D) binding of shampoo-1 selected VHHs in PBS binding in 10% 
shampoo-2. Binding was measured for four different dilutions of ten VHHs each. 
 
These 20 VHHs were tested for binding to Malf1 in PBS, and in the respective 
shampoo used for their selection (figure 2). Eight of the ten shampoo-1 selected VHHs and 
eight of the ten shampoo-2 selected VHHs all bind Malf1 roughly equally well in their 
respective selection shampoo. In both cases one VHH binds significantly worse, and one 
VHH binds significantly better. All but one shampoo-selected VHHs can bind Malf1 in 
PBS, indicating that selection in shampoo normally does not lead to VHHs that require 
shampoo for binding. 
Figure 1 showed that only one of the PBS-selected VHHs could bind Malf1 in 
shampoo. Figure 2 showed that all shampoo-selected VHHs could bind Malf1 in shampoo, 
and that all but one of the shampoo-selected VHHs could bind Malf1 in PBS. Figure 3 
shows the Malf1 binding of the 20 shampoo-selected clones in different concentrations of 
their respective shampoos, and the Malf1 binding of the ten PBS-selected clones in 
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Figure 3. Malf1 binding by VHHs in the presence of shampoo. A) PBS-selected VHHs in shampoo-1 
) PBS-selected VHHs in shampoo-2 C) shampoo-1 selected VHHs in shampoo-1 D) shampoo-2-
 does so equally well as the shampoo-selected VHHs except at 
igher concentrations of shampoo-1.For unknown reasons, it is easier to select for VHHs 
 
The crystal structure of a shampoo-selected VHH (OE7) was determined in order 
to investigate whether the structure of the shampoo-selected VHHs was different from 
VHHs selected under physiological conditions.The Malf OE7 VHH structure is close to that  
 
B
selected VHHs in shampoo-2. 
 
can bind Malf1 in shampoo
h
that can bind Malf1 in high concentrations shampoo-1 than in high concentrations 
shampoo-2. We therefore concentrated our attention more towards shampoo-1 than towards 
shampoo-2 during the remainder of our research. This choice was mainly based on the fact 
that high concentrations (i.e. 10-25%) of shampoo are applied upon washing ones hair and 
the skin of the head. 
 
Crystal structure
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re 3. 
Conformation of 
the Malf OE7 
framework. The 
 area has 
 
 
of other VHHs, besides for the thre
4a). In particular, the loop 39-45 
conserved conformation  
(Figure 4b). Indeed, the pr
Malf OE7 is unknown. In the cr , 
owever, two crevices are well identified close to 
PD molecule from the 
crystallization liquor. The second one, which is 
located on the VHH side, between CDRs 1 and 3, 
crevices, two stretches of residues formed by 
CDRs 1 and 3 protrude from the VHH body. These  
 positively charged patch (blue) formed of 
DR1 and CDR3. 
VHH compared 
to other VHHs. 
A) The overall 
fold of the 
been removed 
for clarity. B) 
The compared 
conformation of 
the loop 38-46. 
e CDRs (Figure 
has a very well 
ecise epitope of 
ystal structure
h
the CDRs. The first one is located on top of the 
VHH (Figure 5a), between CDR1 and CDR2, and 
contains a serendipitous M
and close to the beginning of CDR2 (Figure 5b),  
also contains a MPD molecule. Above these two 
 
Figure 4. The molecular surface of Malf OE7, with the 
3 CDRs displayed in red, green and blue, respectively. 
A) Top view of the combining area with a MPD 
molecule bound. B) Side view of the VHH, with the 
second MPD molecule bound. C) Top view of the VHH, 
with the
C
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ds the solvent in Malf OE7, as well as all the side 
chains in the other VHHs. VHH-R9 bears a Gln residue, as Malf OE7, but VHH-R2, Car24, 
ion 44 bears a Glu residue, while Amy-D10 bear a Gly. 
Position
influence the loop nor the framework conformations.  
 
Malf1 significantly better at high 
ampoo concentrations than the 29 other VHHs that were tested. However, the Malf1 
 PBS is normal compared to all other VHHs. This suggests that 
VHH-D12 has one or more mutations beneficial for Malf1 binding in shampoo. The 
sequenc
VHHs were determined (see figure 6).  
the CDRs of the PBS-selected ones. This might suggest that the hydrophobic tails of some 
of the so
number of the other shampoo-selected VHHs (see figure 6). Three of these positions are 
s, R44 and K75, are located in the framework. In 684 VHH 
sequenc
found only seven times an arginine at postion 44, and 528 times a lysine at position 75. 
stretches are particularly charged positively (Figure 5c), since they bear Arg 30, 97 and 99, 
as well as His 98 (Figure 5c). 
Conformation of the loop 38-45 is very well conserved, whatever residues in 
position 44 are. Gln 44 points towar
amy-B07 and amy-D08 posit
 45 always contains an Arg residue, except for amy-B07 which bears a Cys residue, 
forming a disulfide bridge with its CDR3 (8). None of these substitutions, however, 
Sequence analysis 
The shampoo-1-selected VHH-D12 binds 
sh
binding of VHH-D12 in
es D12, A7, and 6 PBS-selected and 11 shampoo-selected good Malf1 binding 
Not surprisingly, the variability among the PBS-selected sequences is considerably 
higher than the variability among the shampoo-selected ones, especially in the CDRs (see 
figure 6). The CDRs of the shampoo-selected VHHs are on average more hydrophilic than 
ap-like shampoo components shield interactions of antibodies that recognize more 
hydrophobic epitopes. 
A sequence comparison reveals five positions where D12 differs from a significant 
located in CDRs, which make them bad candidates for further analysis in mutation studies. 
Two of these position
es, determined in our other, unrelated experiments on llama antibody fragments, we 
This suggests that R44 might be (partially) responsible for the good Malf1 binding in 
shampoo. The PBS-selected VHH-A7 binds Malf1 reasonably well in shampoo. A7 differs 
at only three sequence positions from D12 (see figure 6). Two of these positions are  
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  r4   . 
  
D12 QVQLQ TQVTVSS
 
S1 QVQLQ TQVPSS 
S2 QVQLQ TQVTVSS
S3 QVQLQDSGGGLVQAGGSLRLSCQASGNISR   INDMG   WYRQAPGTQRELVA   AITTGGSTK------YADSVK GRFTISRDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQGTQVTVSS
S4 QVQLQ --GY   WGQGTQVTVSR
S5 QVQLQ --GY   WGQGTQVTVSS
S6 QVQLQESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTQRELVA   AITTGGSTK------YADSVK GRFTISRDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQGTQVTVSS
S7 QVQLQESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTRRELVA   AITSEGSTK------YADSVK GRFTISRDNAENTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQGTQVTVSS
S8 QVQLQESGGGLAQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTRRELVA   AITSEGSTK------YADSVK GRFTISRDNAENTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQGTQVTVSS
S9 QVQLQESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTRRELVA   AITSEGSTK------YADSVK GRFTISRDNAENTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQGTQVTVSS
S10 QVQLQESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTQRELVA   AITSGGSTK------YADSVK GRFTISKDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQGTQVTVSS
S11 QVQLQESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTRRELVA   AITSEGSTK------YADSVK GRFTISRDNAENTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQGTQVTVSS
 
A7 QVQLQESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTQRELVA   AITTGGSTK------YADSVK GRFTISRDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQGTQVTVSS
 
P1 QVQLQESGGGLVQAGGSLRLSCVASGFTFR   TRAMG   WFRQAPGKEREVVS   VTHSTDIGYS---TYYADSAK GRFTISRDNAKNMVYLQMNSLKPEDTAVYYCG   TSTAVSIAPNEY-----QY   WGQGTQVTVSS
P2 QVQLQESGGGLVQAGGSLRLSCVASGFTFR   TRAMG   WFRQAPGKEREVVS   VTHSTDIGYS---TYYADSAK GRFTISRDNAKNMVYLQMNSLKPEDTAVYYCG   TSTAVSIAPNEY-----QY   WGQGTQVTVSS
P3 QVQLQESGGGLVQAGGSLRLSCAATGRTSS   SYVMG   WFRQAPGKEREFVA   LITFSGGTISYITTYYADSVK GRFAISGDKAKNTVYLQMNNLKPDDTAVYYCA   ADWAARLNSDYQSQSVYDS   WGQGTQVTVSS
P4 QVQLQESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTQRELVA   AITSDGV------TRYADSVK GRFTISRDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRVGTA-------GY   WGQGTQVTVSS
P5 QVQLQDSGGGLVQPGDSLRLSCAASRNIFG   LSRMG   WYRQAPGKQRELVA   TITTGGS------TNYADTVK GRFTISRDNTKNMVYLQMNSLKPEDTAVYYCA   KGWLVKWLPPRDAT---GY   WGQGIQVTVSS
P6   QLQESGGGLVQPGGSLRLSCVASGLPFK   TRAMG   WFRQAPGKEREAVS   VTHSTDIGYS---TYYADSAK GRFTISRDNAKNMVYLQMNSLKPEDTAVYYCG   TSTAVSIAPNEY-----QY   WGQGTQVTVSS
   Fr1                CDR1  Fr2        CDR2    Fr3          CDR3           Fr4 
 Fr1                CDR1  Fr2        CDR2    Fr3          CDR3          F
  10  20     30    40   *       50  *   60  70     80      90   *     103 
ESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTRRELVA   AITSGGSTK------YADSVK GRFTISRDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRVGTV-------GY   WGQG
ESGGGLVQPGGSLRLSCQASGNIFR   INDMG   WYRQAPGTQRELVA   AITTGGSTK------YADSVK GRFTISRDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQG
ESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTQRELVA   AITTGGSTK------YADSVK GRFTISRDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-------GY   WGQG
ESGGGLVQPGGSLTLSCQASGNIFR   INDMG   WYRQAPGTQRELVA   AITTGGSTK------YADSVK GRFTISRDNAKNTVYLQMNSLKPEDTAVYYCA   AEDRHRIGTV-----
ESGGGLVQAGGSLRLSCQASGNIFR   INDMG   WYRQAPGTQRELVA   AITTGGSTK------YADSVK GRFTISRDNAKNTVYLQMNRLKPEDTAVYYCA   AEDRHRIGTV-----
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Figure 6. A) Sequences of VHHs. S1-9 are VHHs that bind Malf1 well in shampoo-1 and S10-11 
bind well in shampoo-2. P1-6 bind Malf1 well in PBS. D12 is the best shampoo-selected Malf1 
binder in shampoo, and A7 is the best PBS-selected Malf1 binder in shampoo. CDRs and framework 
regions are indicated. The five positions where D12 differs from many shampoo-selected VHHs are 
boxed. The three positions where A7 differs from D12 are indicated with an asterix.  
 
located in CDRs, and the third is position 44, which is a Gln in A7. These sequence 
d A7 were 
xchanged. Figure 7 shows the Malf1 binding results of the A7 and D12 wild-type VHHs 
In both denaturants the Malf1 binding is better for the R44 variants 
than for
 
analyses point at an important role for residues at position 44 in the Malf1 binding of VHHs 
in shampoo. To study this effect further, the residues at position 44 in D12 an
e
and the A7-Q44R and D12-R44Q mutants. A clear correlation is seen between the presence 
of arginine at position 44 and Malf1 binding. However, in shampoo this effect is much 
stronger than in PBS. 
To investigate whether the stability caused by R44 was shampoo-specific or more 
general, Malf1 binding of the four VHHs shown if figure 7 was tested in the presence of 
guanidine HCl and urea. Figure 8 shows the result of guanidine HCl and urea titrations of 
VHH-Malf1 binding. 
 the Q44 variants. No binding is observed for any of the four variants above 2 M 
guanidine HCl, or 2.5 M urea, except for A7-Q44R that is still binding Malf1 at 3.5 M urea.  
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Figure 7. Malf1 binding of wild-type and mutant A7 and D12.  A) in PBS. B) in shampoo. 
 
 
Figure 8. Malf1 binding of wild-type and mutant A7 and D12 A) in guanidine HCl B) in urea 
D12
D12R44Q
A7
A7 Q44R
D12
D12R44Q
A7
A7 Q44R
In order to shed light on the enhanced Malf1 binding of VHH variants with an 
arginine at position 44, we also produced the variants A7-Q44K and D12-R44K. The 
rationale behind this experiment is that arginine and lysine both are positively charged 
residues so that these variants potentially could answer the question whether the enhanced 
alf1 binding in shampoo is caused by the introduction of a positive charge, or by specific 
characte
M
ristics of arginine. A lysine and an arginine are structurally comparable, however 
an arginine has a relatively rigid side chain, while lysine has a relatively flexible side chain. 
At pH 11, arginine is expected to be positively charged, whereas lysine is expected to be 
only partially charged at this pH.  
D12
D12R44Q
D12
D12R44Q
A7
A7 Q44R
A7
A7 Q44R
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Figure 9. Malf1 binding of wild-type A7, D12,  mutant A7 Q44K and mutant D12 R44K.  A) in PBS 
at pH 7 B) in shampoo at pH 7C) in PBS at pH 11 D) in shampoo at pH 11. 
 
Figure 9 shows that Malf1 binding of the Q44, K44 and R44 VHH variants is 
significantly reduced at pH 11 in both PBS and shampoo-1. This is not a surprise, as 
proteins tend to be less stable at this pH. At pH 11 the R44 variants still bind Malf1 very 
well in 10% shampoo-1, while the Malf1 binding of the K44 variants is reduced by about a 
factor of two. In PBS, on the other hand, the reduction in the binding of Malf1 is about the 
same for all four variants. This experiment strongly suggests that the enhanced Malf1 
binding in shampoo is caused by the introduction of a positive charge at position 44. 
Discussion 
 
Phage display was successfully performed for the isolation of Malf1 specific VHH 
antibody fragments. Although a lot of VHHs show binding to Malf1 under physiological 
conditions, most of them were shown not to bind Malf1 in the presence of shampoo. As 
Malf1 binding is also strongly reduced in the presence of denaturants like urea or guanidine 
HCl, it seems likely that stability of the VHH is the main determinant for Malf1 binding.  
We used phage display in shampoo to select a series of VHHs that can work well 
in shampoo. It has been observed many times that mutations that protect a protein against 
one type of external stress will also protect the protein against other forms of external stress 
3
3.5
1.2
1.4
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(11, 32). Indeed, the VHH variants that were selected to work well in shampoo also showed 
enhanced resilience against urea and guanidine HCl.  
It was possible to perform the phage display in the presence of high concentrations 
of shampoo to select VHHs that can function well in shampoo. It was surprising that this 
whole procedure worked under such harsh conditions without any major modifications to 
the standard phage display protocols. The growing interest in industry for antibody based 
applications generates a demand for rapid selection and isolation of antibody fragments 
which have high affinity and are stable in the environment in which they should perform 
their function. This paper shows that selection pressure can improve VHH performance in a 
predictable direction. This will eradicate time-consuming improvement of the antibody 
fragments by mutagenesis. 
The phage display helped us detect a series of VHHs with enhanced binding 
roperties. The variability within these sequence families gives a good impression of the 
possible motifs involved in protein stability and binding. Using multiple sequence 
alignment analyses of VHH families one quickly gets good suggestions for site directed 
mutagenesis experiments that can either explain the observations or further improve the 
obtained VHH variants. 
From the analysis of the sequences of 12 shampoo-selected and 7 PBS-selected 
VHHs, we concluded that an arginine at position 44 is important for proper VHH 
functioning in shampoo. This was confirmed by mutagenesis studies. Introduction of a 
lysine at position 44 had equally beneficial effects, indicating that the positive charge is 
n arginine specific characteristics. This is somewhat surprising in light 
that lysine was never observed at position 44 in the VHH variants 
analysed
e 
of the G
concentration of negatively charged molecules. This fact might explain the charged apex 
p
more important tha
of the observation 
 in this study, and only 4 times in 684 VHH variants that we sequenced in previous 
selection studies that had no relation to shampoo. So, even though selection by phage 
display can quickly produce good VHH variants, classical mutagenesis work can still add 
more information. 
The crystal structure of a shampoo-selected VHH was determined. The influenc
ln->Arg mutation is most probably an electrostatic effect. This is supported by the 
fact that a Lys residue induces the same stabilization effect. Indeed, one should keep in 
mind that the harsh medium in which the llama antibodies are raised contains a high 
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ed as naturally occurring, indicates 
selection
Ackn
CDR1 and 3 of the Malf OE7 VHH, as well as the positive effect of the framework 
mutation. The fact that this residue is barely observ
 of a rare subpopulation of VHHs, induced by the harsh medium conditions.  
The proof of the pudding is in the eating. Obviously, the final goal of this project 
is the production of VHHs that can be added to shampoo to reduce dandruff. We have 
produced VHHs that can bind Malf1 under realistic shampoo conditions. It is still to be 
proven that this binding will also lead to neutralization of Malassezia furfur on the scalp. 
However, these VHHs do bind Malf1. So, even if they do not neutralize Malassezia furfur 
they can still be used to deliver anti dandruff agents to the surface of Malassezia furfur. 
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Abstr
 
The trypsin susceptibility was reduced of a llama single domain antibody fragment 
(VHH) that can neutralize rotavirus. The antibody sequence revealed eleven potential 
psin cleavage sites. Analysis of a homology model and a multiple sequence alignment 
entified which of these potential sites were good candidates for mutation studies. Mutants 
inding 
affinity compared to the wildtype. These results show that in silico stabilization can 
ntribute to functional improvement of a VHH, which in this case might lead to an 
onomically feasible product for neutralization of rotavirus for people in developing 
 
Rotavirus is the most common cause of gastroenteritis in young children. It causes 
igh mortality rates in developing countries and is a large economic burden in developed 
countries (Cook et al., 1990 ; Parashar et al., 2003). The importance of rotavirus has 
imulated much research into vaccine development (Cunliffe et al., 2002). Presently, the 
est vaccine that is available (Joensuu et al., 1997), RotaShield, is associated with 
intussusception (MMWR, 1999). Therefore this vaccine has been withdrawn from the 
arket (MMWR*, 1999; Miller, 1999).  
Several studies have illustrated the feasibility of the use of orally administered 
antibodies for the inhibition of viral infection (Dagan and Eren, 2003; Burrer et al., 2003). 
everal groups have reported the inhibition of rotavirus with antibodies (Sarker et al., 2001; 
udert et al., 2002). A large disadvantage of the use of antibodies is that they have to be 
administered orally.  This implies that the antibodies have to pass the gastrointestinal tract 
here they are exposed to gastric acid, high concentrations of bile salts and other small 
molecules, and digestive enzymes. Petschow showed that the activity of antibodies in the 
gastrointestinal is mainly decreased by low pH and trypsin (Petschow and Talbott, 1994).  
act 
try
id
were analyzed on trypsin susceptibility, rotavirus binding affinity, production levels, and 
thermostability. Mutation of position 27 decreased trypsin susceptibility and increased 
thermostability. Mutant R27A also showed increased production levels and equal b
co
ec
countries. 
Introduction 
h
st
b
m
S
L
w
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Rotavirus infections seem independent of the hygienic state and are so widespread 
 74
entire world population will have been infected before the age of five. 
lmost all of the 440.000 deadly rotavirus infections involve children in developing 
countrie
000 et al.; Thomassen et al., 2002), they can easily be cloned, and display 
rez et al., 2001; Dolk, manuscript submitted).  
 must resist low pH and pepsin in the stomach and trypsin in the 
intestines. The low activity of trypsin at low pH precludes the simultaneous optimisation 
against t
n is required for cleavage of viral protein VP4 into 
VP5 and
s 
that nearly the 
A
s (Parashar et al., 2003), so that a method to prevent infection necessarily must be 
cheap. This cost argument, at first, seems to eliminate the use of antibodies as a viable 
approach, particularly in developing countries.  
Members of the family of the Camelidiae, like camels, dromedaries and llamas 
have been shown to possess a unique subclass of antibodies lacking light chains (Hamers-
Casterman et al., 1993), and consequently have only a single binding domain. This variable 
domain of a heavy chain antibody is called a VHH. VHHs have several advantages over 
conventional antibodies, that make them promising tools for a wide range of applications 
(Van der Linden et al., 1999; Ledeboer et al., 2002; Dumoulin et al., 2003; Verheesen et 
al., 2003). VHHs are very cheap to produce, because of high production levels in yeast 
(Frenken, 2
reversible unfolding (Pe
A useful VHH
hese three hazards with simple phage display selection techniques. As there exists 
little experience in engineering protein stability against low pH, we have used phage 
display to select VHHs that can survive stomach conditions and neutralize rotavirus in vivo 
(Van der Vaart, manuscript in preparation). In this study we describe the additional 
protection of one good candidate VHH, VHH1, against trypsin in the intestines by protein 
engineering. 
For most rotavirus strains trypsi
 VP8 in order to infect efficiently (Gilbert and Greenberg, 1998). Even though 
trypsin is essential for rotaviral infection, trypsin inhibitors cannot be used for prolonged 
protection because trypsin has too many important functions. Trypsin is one of the most 
abundant proteases in the intestines, and it has been shown that it can decrease the 
neutralization effect of antibodies dramatically (Blum et al., 1981; Hilpert et al., 1987; 
Petschow and Talbott, 1994; Pacyna et al., 2001). If prolonged protection against rotavirus 
is necessary, the antibody fragment should not be susceptible to trypsin. Trypsin cleaves 
Arg-Xxx and Lys-Xxx bonds. The cleavage efficiency depends on the local sequence a
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describe
s;  
Mate
The structure of VHH1 was modelled based on a multiple alignment of sequences 
from all available PDB structures and VHH1 sequence using ClustalW. The model was 
build using the WHAT IF software (Vriend, 1990) based on the structure of the VHH 
directed against RR6, PDB entry 1QD0 (Spinelli et al., 2000), as described previously 
(Vriend and Eijsink, 1993). Modelling details at http://www.cmbi.kun.nl/articles_ext/. 
 
d by Frenken (Frenken et al., 1993) and on the local three-dimensional structure 
(e.g. Hubbard et al., 1994). The potential trypsin cleavage sites in VHH1 were analyzed, 
and the most likely tryptic cleavage sites were removed by mutagenesis. The mutated VHH 
should favourably compare to the wild-type according to the following criteria: 
o Less susceptible to trypsin;  
o At least equal production level
o At least equal binding affinity; 
Normally, all mutations that improve the hydrogen-bonding pattern, increase the 
buried hydrophobic surface area, add a salt bridge, etc., while not simultaneously 
introducing strain or other bad side effects, will improve the overall protein stability, 
independent of their location in the protein. However, if the inactivation process is 
irreversible, it only makes sense to mutate at, or around the location where the first 
irreversible step takes place. In case of proteolysis, it has been shown that increased 
stability can only be obtained by mutations that reduce the first cleavage step (Frenken et 
al., 1993; Van den Burg et al., 1998). 
We determined that the arginine at position 27 (R27) (numbering according to 
Kabat (Kabat et al., 1991)) is the first tryptic cleavage site in VHH1. Mutation of this 
arginine to alanine (R27A) leads to a dramatically decreased proteolysis. Additionally, 
R27A fulfills the aforementioned criteria. This mutant seems a good candidate to start 
inhibition of rotaviruses in the gastrointestinal tract. Its combined properties allow for the 
economically feasible production required for large-scale application in developing 
countries, where rotaviral infection is a big problem.  
rials and Methods 
 
Homology modeling 
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bed before 
(Frenken et a erformed with 703 public and proprietary 
sequences of es on llama antibody fragments. All 
numbering an bat (Kabat et al., 1991). 
desired mutation. These products were digested with restriction enzymes and cloned into 
Strains
The Escherichia coli strain used for plasmid (pUR4585) propagation was TG1. 
This strain was grown in 2TY medium with 100 µg/ml ampicillin and/or 1% (v/v) glucose 
when appropriate. Transformation to yeast was performed as described before (Gietz and 
Woods, 2002). 
The VHHs were produced in Saccharomyces cerevisiae VWK18 gal1. Individual 
colonies were transferred to test tubes containing selective minimal medium (comprising 
d were grown for 18 h at 30°C. Subsequently, the 
ium (comprising 1% yeast extract, 2% bacto 
pepton) and 2% glucose. 2% galactose was added for induction. After 48 h of induction, the 
cells were harvested. Antibody fragments were purified with TALON (Clontech) according 
to the m
ples 
were taken. Immediately protein sample buffer was added and the samples were boiled for 
Mutant design 
The accessibility of the arginine and lysine residues in VHH1 was determined 
using the surface-accessibility module of WHAT IF (Vriend, 1990). The compliance with 
the serine protease specificity rules of Frenken was determined as descri
l., 1993). Multiple alignments were p
 VHHs as obtained from previous studi
d CDR definitions are according to Ka
 
Construction of the mutants 
Mutants of VHH1 were created with PCR by ‘splicing by overlap extension’ (Ho 
et al., 1989). In short, complementary primers, with nucleotides substituted for generating 
the desired mutation are used in a two-step PCR to generate DNA fragments containing the 
vector pUR 4585 containing a Myc-tag and a His-tag (Van der Linden et al., 2000). 
 
 and growth media 
0.7% yeast nitrogen base, 2% glucose) an
cultures were diluted ten times in YP med
anufacturer’s protocol. 
 
Trypsin digestion 
Eight µg of VHH was incubated with 20 µl immobilized TPCK trypsin (Pierce) in 
PBS at 37°C. After 0, 15, 45 and 90 minutes of head-over-head incubation, 10 µl sam
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re stored at -20°C until all samples were collected, and subsequently 
separate
CD spectra were measured with a Jasco J-810 spectropolarimeter coupled to a 
Jasco CDF-426S Peltier thermostatted cell holder. Molecular ellipticity at 200 nm was 
determined from 25°C to 80°C. The spectral bandwidth was automatically kept at 2 nm, the 
temperature increment was 0.2 C/step and the accumulation time was 2 C/min. 240 µg/ml 
2 uarz cuvette (Hellma). The spectra manager software 
(Jasco) 
Functional assay 
etermination of the binding capacity of the mutants was performed in a 
UV-inactivated bovine (Compton) rotavirus strain G3 
CK5 wa
utants. The highest concentration of 50 µg/ml and samples were diluted 
with 2%
was performed with 25 µg VHH1 WT without tags and 
25 µg R  with tags dissolved in 100 µl PBS with 50 µl trypsin beads (Pierce). After 0, 
ernight samples of 15 µl were taken, to which 5 µl soy bean trypsin 
inhibitor 
5 min. Samples we
d with SDS PAGE.  
 
Determination of TM 
VHH in H O was used in a 0.2 mm q
was used to analyze the spectra. Typically, the spectra of the VHHs were 
smoothened and the first derivative was determined.  
 
D
competition ELISA based assay. 
s coated onto maxisorp plates. Plates were blocked for 30 minutes with 4 % 
MPBST (4% Marvel in  PBS with 0.05% Tween20). Fifty µl of 250 ng/ml VHH1-biotin in 
2% MPBST was added to 50 µl of competition samples. Competition samples contained 
VHH1 or the m
 MPBST. Subsequently this mixture of biotinylated VHH1 and competitor were 
incubated for one hour. After washing, streptavidine-HRP (1:1000 in 2% MPBST) was 
added to all wells and incubated for one hour. Subsequently, the plate was washed and HRP 
activity was determined with TMB substrate (Biomerieux, Boxtel). The color reaction was 
stopped with 50 µl H2SO4 and measured at 450 nm in a plate reader.  
Determination of the binding capacity after trypsin digestion was performed using 
the same assay. Trypsin digestion 
27A
90, 180 minutes and ov
(5µg/µl) was added. These VHH samples were diluted to 50 µg/ml in 2% MPBST.  
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Results and discussion 
 
There are no structures available of anti-rotavirus antibody fragments yet. 
HH1 was obtained by homology modelling using the VHH  
 
purple. The side chains of the eleven arginines and lysines are shown as sticks. The yellow residues were mutated; 
the blue ones not. B) Sequence of VHH1. The hexapeptides shown in table 1 are underlined. CDRs are in purple. 
The eleven arginines and lysines are in red, while bold-face indicates the six residues that were mutated. 
Therefore the structure of V
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A) Model of VHH1. Strands are represented by red arrows; loop areas by green tubes; the CDRs are 
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inelli et al., 2000). One consideration in this 
mplate choice was the large number of conserved arginines and lysines between 1QD0 
and VH
at 
http://www.cmbi.kun.nl/articles_ext/. 
Figure 1 shows the VHH1 model 
with the arginines, lysines, and the 
hyper variable domains (CDRs) 
ndicated. Table 1 lists the sequence 
patterns around the eleven arginines 
and lysines. In this table compliance 
with the serine protease specificity 
ules of Frenken (Frenken et al., 
1993) is indicated. 
 
 
 
 
 
 
Table I:  
Compliance with Frenken’s sequence 
rules for serine protease specificity and 
accessibility. Six residues around each of 
the eleven trypsin cleavage sites in VHH1 
are shown and + and – signs indicate 
compliance or non-compliance 
respectively. The right hand column 
indicates the accessible surface area of 
the side chains of the arginines and 
against hapten RR6 (PDB file 1QD0; Sp
te
H1. Modelling details such as the list of potential templates, the alignment of 
template and model sequence, alignment scores, etc., are available 
i
r
R17              187.9     
V   G  D   R   L   S   
+   + -   +   -   -   
 
R27             202.3     
A   S G   R   T   F   
-   + +   +   -   +   
 
R38             50.9   
A   W F   R   Q   A   
-   -  -   +   -   -   
 
K43             159.3     
A   P G   K   E   R   
-   -  +   +   -   +   
 
R45             177.4     
G   K  E   R   E   F   
-   + -   +   -   +   
 
K64             109.2     
D   A G   K   G   R   
-   -  +   +   +   +   
 
R66             80.1   
G   K  G   R   F   T   
-   + +   +   -   -   
 
R71             44.6   
T   I  A   R   V   N   
-   -  +   +   -   +   
 
K75             126.9     
V   N A   K   N   T   
-   + +   +   -   -   
 
R84             1 5 6.6     
H   M N   R   L   K         
 
        
      
     
   
  
  
 
   
 
     
   
 
     
 
 
      
lysines at the P1 position (fourth residue 
of the six). Residues that were chosen for 
mutation analysis are boxed.  
+ - - + - +
K86         
N R L K P E 91.2 
- + - + + +
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listed in table 1. Several groups have studied loc
irreversible inactivation by proteolytic cleavage. (
(Hubbard et al., 1994) used molecular dynamics techn
local unfolding processes, and found that the required
displacement of atoms in the substrate. Vriend and
however, found that this small local displacement can
are close to those required for global unfolding. W
unfolding required for cleavage by trypsin is related to
the arginine or lysine adjacent to the scissile bond. 
Frenken rules and the surface accessibility of the argin figure 2 
these results are represented graphically. Since both factors are important for proteolysis, it 
is to be expected that residues in the upper right corner of e plot are more likely to 
represent the major cleavage site than residues in the lower left corner.  
Based on figure 2 we selected R17, R27, K43, R45, 64 and K86 for mutation. 
Until now, the relative importance of the Frenken rule comp ance on the one hand and 
structural considerations like the accessible surface areas of the side chains on the other is 
unknown. The diagonal line drawn in figure 2 is there a qualitative indicator. 
Figu
the e
The 
is gi
resid
comp
The 
with 
with 
prote
Frenken’s rules for serine protease specificity include four residues before and two 
residues after the scissile bond. The dominant rule is, of course, that the fourth residue must 
be an arginine or lysine. Cleavage by trypsin requires local unfolding of the substrate 
protein to allow proper docking in the active site cleft of trypsin of at least the hexapeptides 
al unfolding processes that preceed 
e.g. Eijsink et al., 1992). Hubbard 
iques to study the magnitude of these 
 unfolding is small in terms of atomic 
 Eijsink (Vriend and Eijsink, 1993), 
 only take place under conditions that 
e reasoned that the degree of local 
 the degree of surface accessibility of 
Table 1 lists the compliance with the 
ines and lysines in VHH1. In 
 th
 R
li
fore only 
 
 
re 2. Trypsin cleavage probability of 
leven arginines and lysines in VHH1. 
accessible surface area of the side chains 
ven on the abscise, and the number of 
ues in the hexa-peptide (see table 1) that 
ly with the Frenken rules on the ordinate. 
diagonal line separates the top right half 
likely candidates from the bottom left half 
less likely candidates for being the major 
olytic site. 
Frenken-accessibility plot
0
1
2
3
4
5
0 100 200 300 400
accessible surface
F
re
n
k
e
n
 p
o
s
it
iv
e
s
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eins and the wild-
type in t
 and 
purification of VHH1 
tants. A) intracellular 
medium supernatant on a 
PAGE gel. C) purified 
 the intracellular 
supernatant (right) on a 
massie stained SDS-
PAGE gel.  
In the absence of other considerations than structural integrity, it is always best to 
introduce alanines when making mutations, because the introduction of alanines normally 
does not lead to sterical strain. Except for K43 we mutated all six residues into alanine. A 
multiple sequence alignment revealed that K43 is highly conserved in VHHs; 87,1% of the 
703 sequences have K43, 4.4% have N43, and 2.3% have T43. Other residue types are not 
observed in a significant number of sequences. T43 was often found in selection 
experiments designed to find VHHs that are stable in the presence of anionic tensides 
(Dolk, manuscript in preparation). A combination with the fact that bioinformatic analysis 
of the VHH1 model showed that asparagines would not fit well at position 43 led to the 
decision to choose K43T. The alignment also revealed that serine and phenylalanine were 
observed rather frequently at the positions 17 and 27 respectively. Therefore we decided to 
also make the mutants R17S and R27F.  
One of the criteria was that mutant production-levels in yeast must at least be 
equally to that of the wild-type. Additionally, secretion to the medium is required to reduce 
purification costs in a later mass-production stage. The mRNA level of the VHHs was 
checked on a Northern blot. All mutants show comparable amounts of mRNA (data not 
shown). Figures 3a and 3b show the production level of the mutant prot
he intracellular fraction and in the growth media, respectively. These results  
 
 
Figure 3: Production
mu
from
16 kD
10 kD
fractions on a Coomassie 
stained SDS-PAGE gel. B) 
Coomassie stained SDS-
fractions of the mutants 
fraction (left) and from the 
Coo
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Figure 4 Digests of the mutants before, and 15, 45, and 90 minutes after addition of trypsin on a 
Coomassie stained SDS-PAGE gel. Protein ladder is indicated with M 
 
The remaining seven mutant proteins were subjected to t
second amino acid of the Myc-tag is a lysine, and the tags are likel
thus susceptible to tryptic cleavage.Figure 4 shows that most mutan
coomassie stained gel. The upper band is the intact VHH with the 
band is the intact VHH without the tags. This was confirmed by W
and anti-VHH antibodies (data not shown). The third band is the VHH1 degradation 
product. The mutants R27F and R27A do not show this third ba
mutants are not cleaved. The size of the degradation product 
corresponds well with VHH1 without the first 27 amino acids. Posi
the first tryptic cleavage site.  
 
indicate that mutants R27F and R27A even have higher production levels than the 
wild-type, and are also better secreted. Mutant K43T is hardly secreted, while R17A and 
R17S show reduced secretion. It has been shown before that (single) amino acid 
substitutions can influence the secretion of heterologous proteins by S. cerevisiae 
significantly (Sagt et al., 2000). Figure 3c shows the VHHs that were purified from the 
intracellular fraction and growth media, respectively. Mutants R17S and R17A are mainly 
obtained from the intracellular fraction and mutants R27F and R27A mainly from the 
growth medium. K43T could neither be purified from the intracellular fractions, nor from 
the growth media and will therefore not be analysed further. 
R17S               R17A                   R27F              R27A
M Mt= 0   15  45   90       0   15   45  90 0   15  45   90       0    15   45  90
K64A K86A                    R45A
10kD
16kD
 
ryptic digestion. As the 
y to be very flexible and 
ts show three bands on a 
Myc-His tag, the middle 
estern blot with anti-his 
nd, indicating that these 
is about 12 kD, which 
tion 27 of VHH1 is thus 
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Figure 5  Digestion of wildtype and R27A by trypsin on a Coomassie stained SDS-PAGE gel. A) 
Tryptic digest of wild-type VHH1 before, and 15, 45, 90, 180, 360 minutes and overnight digestion of 
trypsin. B) As A, but for R27A.  
Figure 5 shows the results of prolonged tryptic digestion of R27A and the VHH1 
wild-type. After 45 minutes, 50% of the wild-type is degraded, and after 180 minutes only 
 15 
 24 hours. This assay was 
only per rmed on R27A and not on R27F for reasons described below. 
hat the inactivation occurs after subsequent cleavages that  
t=      0          15      45      90      180    360    on
A
B
very little VHH1 is left. Mutant R27A shows complete removal of the tags after
minutes. No significant further degradation of R27A is seen up to
fo
A competition ELISA assay was performed to check that the mutants were still 
able to bind rotavirus, and to estimate their binding affinities. Figure 6 shows the results of 
competition experiments comparing biotinylated VHH1 and varying concentrations of the 
non-biotinylated mutants or wild-type. All variants show binding affinities comparable to 
wild-type, except R27F, which showed a significant decrease in affinity.  
It can be seen in the sequence of VHH1 (figure 1B) that cleavage at position 27, as 
it is just in front of CDR1, does not necessarily influence the integrity of the CDRs under 
these experimental conditions. Figures 4 and 5 indicate that the degradation product after 
cleavage at position 27 is present. The question arises whether this first cleavage renders 
the VHH1 already inactive, or t
Chapter 4                                                                                                        _ 
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re 6: Binding 
ty competition 
experiment. 250 ng/ml 
lated VHH1 and 
ing concentrations 
(as indicated on the 
horizontal axis) of non-
ylated variants 
ete for rotavirus 
binding. OD450 is 
related to binding of 
lated VHH1. The 
horizontal red line 
ates the maximal 
signal, obtained from 
lated VHH1 
without competition. 
 
he first 27 amino 
27A mutation is  
after 90 minutes, 180 
tes and overnight 
(0) was set at 100 %.  
e 
arrow indicates SBTI.  
 
 
are made possible by the initial cleavage at position 27. Figures 5A very clearly shows the 
degradation of VHH1 as a function of time. Surprisingly, figure 7A and 7C show that 
rotavirus binding does not decrease appreciably after limited digestion of t
acids.  
R
A
100
After prolonged digestion, when second site cleavage has occurred (see figure 5) 
the rotavirus-binding capacity of the wild-type decreases. R27A neither gets cleaved, nor 
looses its rotavirus-binding capacity under these conditions. So, the partially cleaved VHH1 
is still capable of binding rotavirus, and it can thus be concluded that the 
 
Fig 7. Competition 
capacity of  A) wildtype 
and B) R27A without 
trypsin digestion, and 
minu
B
0
20
40
60
80
0
20
40
80
100
digestion with trypsin. 
Competition capacity 
before trypsin digestion 
The Coomassie stained 
gels of samples used for 
A and B are shown in C 
and D respectively.Th
0     90   180 on
D
2 3 4
60
1 2 3 41
0    90   180  on
C
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important because it prevents subsequent cleavage at other sites. Th binding capacities of 
the samples used for figure 7 were tested similarly as described for fi re 6, but in this case 
the competition was measured only against one concentration on non
Trypsin inhibitor did not have any effect on the binding efficiency 
(data not shown). Note that tags are efficiently cleaved from R27A
this cleavage does not affect binding (figure 7D). 
Several groups have indicated that thermal stability of protei
indicator for stability against a series of irreversibly inactivating c
Sauer, 1989; Eijsink et al., 1992). The corollary does not necessaril
mutants were designed with avoidance of proteolysis as the major co
considerations were minor. Figure 8 shows the results of thermal un
wild-type and the seven mutants. The wild-type and the seven mut
cooling. This important feature of VHHs has been observed before (Perez et a 1).  
It is somewhat surprising to observe a correlation between the global unfolding 
from the tryptic digestion (figure 4). We managed to purify a very small amount of K43T 
and estimated its global unfolding temperature around 60 C from the experimental results 
obtained with this fraction. It is likely that global stabilization will also reduce the ease of 
local unfolding, but the underlying mechanisms are hard to grasp and certainly beyond the 
scope of this article. The observed increase in thermostability of mutant R27A has 
advantages for many steps along the entire line from design and purification to mass-
production, pasteurisation and therefore shelf life, and real-life application in developing  
Figure 8. The
) Thermal m
obtained with 
ine 2 was 
own. B) First
urve in A. C)
lists the 
corresponding
the derivative c
e 
gu
-biotinylated material. 
of biotinylated VHH1 
 after 90 minutes and 
ns often is also a good 
onditions (Parsell and 
y need to be true. The 
nstraint while stability 
folding studies of the 
ants all refolded upon 
l., 200
around 65 °C as measured by CD (figure 8) and the local unfolding at 20 °C as deduced 
°
 
 
A
L
d
c
(
Wildtype
-30
0
30
25 35 45 55 65 75
temperature
m
ol
ec
ul
ar
 e
lli
pt
ic
ity
First derivative
-3
0
25 35 45 55 65 75
A
B
C
temperature
R17S 64.2
R17A 63.2
R27F 68.4
R27A 67.4
R45A 62.8
K64A 62.8
K86A 63.2
WT 64
1
2
rmal denaturation data. 
elting curve of VHH1 
CD spectroscopy (line1). 
obtained upon cooling 
 derivative of the heating 
 The right-hand column 
melting temperatures 
 to the negative peak in 
urves).  
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ng VHHs against rotavirus that are stable 
under sto
this reduction is caused by steric hindrance upon virus binding caused by the phenylalanine 
not disagree with that observation. 
In summary, the R27A mutant fulfils all requirements (stability, production, 
binding), and thus is a good candidate for further stud ample, it still has to be 
shown that good in vitro binding correlates with good
trypsin concentration used in our in vitro studies is rou
the human intestines. However, the gastrointestinal tra
his production at the toilet might easily realize, cont
pepsin, trypsin and acid. In vivo tests will have to shed
hopeful that this successful mutation study has gener
antibody based cure for rotavirus infections. 
countries. The next step will be animal tests with R27A to see if the in vitro improvements 
allow for rotavirus neutralization with lower doses than the wild-type.  
Conclusions 
 
We have selected a subclass of neutralizi
mach conditions. To improve the application of these VHHs in the gastrointestinal 
tract the goal of this study was reduction of tryptic digestion of VHH1 through site-directed 
mutagenesis. The mutants should produce well and neutralize the rotavirus. We introduced 
the Frenken-accessibility plot to qualitatively predict which arginines and lysines are most 
susceptible to tryptic digestion. Despite its crudeness, this method worked very well in this 
study. It should, however, be kept in mind that this is only one study with just a few data 
points. 
The R27A and R27F mutants both show increased resistance against trypsin and a 
higher melting temperature. R27A shows, like the other six mutants, affinity similar to the 
wild-type, which indicates that arginine 27 is not directly involved in virus binding. 
Surprisingly, rotavirus binding of R27F, on the other hand, is strongly reduced. Probably, 
side chain. 
Kowalski (Kowalski et al., 1998) saw a correlation between thermal stability of 
proteins and their secretion level in yeast. Our data, albeit limited in numbers, at least do 
ies. For ex
 in vivo neutralization. Further, the 
ghly similar to the concentration in 
ct, as every man who ever watched 
ains many more compounds than 
 light on these questions, but we are 
ated an excellent candidate for an 
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Abstr
 
marks for 
the single binding domain of the heavy chain antibodies (VHH). These residues occupying 
e VL-interface in the VH of conventional antibodies are almost always substituted in the 
HH of heavy chain antibodies. These substitutions led to a more hydrophilic patch 
 and VHH sequences, focusing on residues in the (former) VH-VL interface 
area. Furthermore we provide evidence for  a role of these residues in the stability of 
HHs. 
An antibody normally consists of two identical heavy chains and two identical 
ght chains. Both chains are build up by several domains. Constant domains (C), relatively 
conserved domains, and variable domains (V) functioning as the binding domains of the 
ntibody. The variable domain of the heavy and the light chain (VH and VL) form the 
inding unit of an antibody. These two domains are interconnected by disulphide bridges 
which are formed after interaction of the hydrophobic interfaces of the VH and VL.  
Camelids possess next to these conventional antibodies, a subset of antibodies 
lacking the light chains (Hamers-Casterman, 1993). These antibodies are known as heavy 
chain antibodies. The variable domain of the heavy chain of these heavy chain antibodies 
(VHH) is therefore the single binding domain. The lack of the VL would have left a 
unfavourable hydrophobic patch in VHHs. However, VHHs are well adapted to their single 
domain status (Van der Linden, 1999; Muyldermans, 2001) 
One of the hallmarks of VHHs, clearly showing this adaptation, can be seen 
comparing VHHs with conventional VH domains. A number of hydrophobic residues in 
VH domains are constitutively substituted to more hydrophilic residues in VHHs. These 
substitutions reside in the VL-interface of VH domains. VHHs, lacking the VL, do not 
act 
Four amino acid substitutions from VH to VHH were designated as hall
th
V
compared to the hydrophobic interaction site as seen in conventional antibodies. This 
clearly shows the adaptation of the VHH to its single domain status. Three seemingly 
unrelated studies showed that residues in this area are not only important for the solubility 
of the VHH, but can also be key determinants for the stability of the VHH. Here, we 
compare VH
V
 
1. Differences between VH and VHH 
li
a
b
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we will call the ‘former’ VH-VL interface.  
Other mechanism showing adaptation to the single domain status have been 
describe
nelli, 2001). 
The higher variability in sequences and the use of framework residues in binding 
e three binding loops of the VL (Nguyen, 
2000). It
 could 
explain 
imited to a number of 
residues
this area, which 
d as well (Muyldermans, 2001). First, a longer CDR3 is often seen in the VHHs. 
This extention of the third binding loop can compensate for the lack of the three CDRs of 
the VL (Desmyter, 2001), which normally, together with the three CDRs of the VH, form 
the binding region. This longer CDR3 of the VHH does not only enlarge the contact surface 
of the antibody fragment with the antigen, it also enables a higher variety of binding motifs. 
In VHHs long CDR3s have been implicated to be able to protrude the active clefts of 
enzymes, thereby inhibiting or modulating their activity (Transue, 1998). This was thought 
to be difficult with conventional antibodies, which often bind their antigen in a binding cleft 
between VH and VL. A long CDR3 has also been implicated to be able to cover the 
‘former’ VL-interaction site and bind the antigen similar to a VH-VL pair, only without the 
VL (Spi
of the antigen shows adaptation to the lack of th
 has been suggested that CDR1 was enlarged to cover residues 27-35 (Nguyen, 
2000). Residues 27-30 in VHH show a higher variability compared to VH domains. 
Normally, the substitutions observed in the germline, F27Y and F29Y, would not have a 
major impact on the variability of the loop. However, with these mutations, the codon of 
Phe TTY (where Y is T or C) has been changed into TAY for Tyr. This change in codons 
results in the introduction of two hotspots for somatic mutation (Milstein, 1998). This
the higher variability of residues 27-30 in VHHs and implicates that these residues 
have become important in binding the antigen. Furthermore, the longer CDR1 will, like the 
prolonged CDR3, give more flexibility in antigen binding.  
 
2. The ‘former’ VH-VL interface in VHH domains 
The VH-VL interactions in conventional antibodies are l
. In the VH: S/H35, V37, Q39, L45, W47, F/Y91, A/L93, X951, F/Y100*2 and 
W103. (1 Not conserved, CDR3 residue. 2 Residue three positions before W103, in CDR3) 
are the ten residues normally in contact with the VL (Vargas-Madrazo, 2003). S/H35, V37, 
A/L93 and X951 have been reported to have little or no contact with the VL (Vargas-
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 a hydrophobic plain, which 
enables 
Most striking is of course the substitution of the four amino acids 
already m
eu at position 11. This might 
suggest that mutation of L11 could have structural implications in llama VHHs, which have 
estigating the importance 
of L11 in llama VHHs.  
Position 35, although not in very tight contact with the VL, is located in the VH-
Madrazo, 2003). This leaves Q39, L45, W47, F/Y91, F/Y100*2 and W103 in close contact 
with the VL. These, all large, mostly aromatic residues form
hydrophobic interactions with the VL .  
In camelid VHHs four residues, substituted from VH to VHH,  V37F, G44Q/E, 
L45R and W47G/F/L, have been designated as hallmarks for VHHs on many occasions 
(Vu, 1997; Harmsen, 2000; Muyldermans, 2001). Remarkably, but not surprisingly, these 
substitutions are in the region where normally the VL interacts with the VH. The other 
residues in this area of the VHH also show some remarkable substitutions, compared to 
VH. Table 1 shows the residues which have been shown to interact with the VL in VHs and 
their distribution in 700 VHHs, currently present in our database. Residue 11 was taken into 
account because this residue was shown to interact with the CH1 domain in VHs (Padlan, 
1994). The CH1 domain is not present in VHHs. Two residues, position 43 and position 46, 
which are in the interface with the VL, but not directly in interaction with the VL, were 
added to this table. 
entioned. However, there are some other noticeable substitutions, although not as 
conserved as the four mentioned above. Mainly, large, aromatic and hydrophobic residues 
are substituted for charged hydrophilic residues. 
A conserved Leu at position 11 was reported to be part of a ball-and-socket 
connection between the VH domain and the CH1 domain (Lesk, 1988). In camelid VHHs, 
lacking the CH1 domain, this L11 is likely to be mutated because of the solvent exposed 
nature of this hydrophobic residue. Indeed, in dromedary sequences this L11 was 
consistently substituted into S11 (Vu, 1997), suggesting the replacement into a smaller and 
more hydrophilic residue, to make the VHH more soluble. However, in the llama, also 
lacking the CH1 domain, this substitution is not conserved. Surprisingly, 84% of the VHHs 
in our database, primarily llama sequences, contained a L
already been overcome by dromedary VHHs. It is worthwhile inv
VL interface. Vargas-Madrazo and co-workers showed that position 35 is predominantly 
occupied by Ser (40% in human VHs) or His (21% in human VHs), and in 97% of the cases 
orientated towards the antigen binding site (Vargas-Madrazo, 2003). In VHHs, Ala (36%)  
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Table 1. Distribution of residues in the (former) VH-VL interface in VHs (Vu, 1997; Vargas-
Madrazo, 2003) and camelid VHHs. 
1 2 Position VH VHH Perc (%) Position VH1 VHH2 Perc (%) 
11 L L 84.1 46 E E 91.0 
  S 11.5   D 5.8 
  X 4.4   X 3.3 
35  A 36.0 47 W F 36.4 
  G 18.8   L 35.6 
  D 7.6   G 12.0 
 S S 6.9   X 16.0 
 H H 1.9 91 Y Y 84.1 
  X 28.9  F F 5.0 
37  F 55.8   X 10.9 
  Y 40.9 93 A A 57.3 
39 Q Q 94.8   X 19.2 
  X 4.2 
 V V 0.6   N 23.4 
  X 2.6   L 0.0 
95  R 19.8 
 
and Gly (19%) are the predominant amino acids, suggesting a different role for 
this position in VHHs. The introduction of two hot spots for somatic mutation at position 
27 and 29 can enlarge CDR1 from residue 31-35 in VHs to 27-35 in VHHs (Nguyen,
43 K K 85.5  D D 16.5 
  T 4.2   E 7.8 
  N 4.2   K 4.2 
  Q 1.7  G, Y, S X 51.6 
  X 4.4 100*  ND  
44  E 56.9 103 W W 95.8 
  Q 29.9   R 1.7 
  R 2.3   E 0.3 
45 L R 97.2     
  C 1.2     
  X 1.6     
 G X 10.9   X 2.2 
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binding. It could be that this position becomes more 
important as a residue important for orientation of CDR1 and connecting the two β-sheets. 
The high occurrence of G35 in VHHs supports this hypothesis.  
osition 35 tog er wit ition 95 were de ribed as importa for the 
‘proxima  zone’  con tional odies (Vargas-Madrazo, 20  This ximate 
zone’ is ined by the re ues in terface, which are st pro
binding. These res es are often i d in ant en bindi nd it thus no rising 
that less ydrophi  resid  like D re abund nt. Gly, Tyr, and residu  often 
observed at posit  95 as well, in ing that t is residu uld be respons or the 
formation of the h ropho  cleft o seen bet n VH a VL. In ma VH osition 
95 is hig ariab  as w but ch , hydrop d  are pre minant ain 
shows, although less prom t, ada n to the lack of VL
Likewise, at position 93 a Ala is often seen in VH as well as in VHH. However, an 
Asn is also observed in 24% of the VHHs. Although not as prominent as the previous 
mutatio is als akes VHH hydroph ic. 
wo Trp residues are ver inent the con ct betw  VH a L. As 
shown i ble1 W47 is s ituted VHHs a d is cons red the llmark amelid 
heavy ch n antibodies. S risingly 103 is st ighly c ed, 95.8 % o  VHHs 
still have 03, although en mutated an R or E is seen in 3 out of the 27 su tutions. 
This indi tes that the fun n of th o Trp residues is ely erent. tion 
of W47 ortant r solub ile  might ave a  structural role in 
VHHs a uld b por t for correct foldin tabilisa  of th ner co
It was shown by so-called ‘camelizing’ of human VHs that one of these 
substitutions V37F has an effect on the thermostability of a human VH domain (Davies, 
1996). Davies and Riechmann al ggested that mut ions in FR2 coul have a 
significa  effect o  stability and pro tion levels (Davies, 1994). We btained results that 
indicate an effect f mu ons in esidin  in the ‘ er’ V -VL int , on 
stability and production levels in a series of independent experiments.  
2000). This extention of CDR1 towards the N-terminus might result in a less prominent 
role for position 35 in antigen 
P eth h pos  sc nt 
te in ven antib 03). ‘pro
 def sid  the in  mo ximate to the antigen 
idu nvolve ig ng a is t surp
h lic ues 95 a a Ser es are
ion dicat h e co ible f
yd bic ften wee nd  lla Hs p
hly v le ell, arged hilic resi ues do . This ag
inen ptatio . 
ns th o m  the  more il
T y prom  in ta een nd V
n ta ubst  in all n ide  ha  for c
ai urp , W ill h onserv f all
 W1  wh  1 bsti
ca ctio e tw  complet diff Substitu
will be imp  fo ility, wh W103  h more
nd co e im tan g or s tion e in re.  
so su at d 
nt n duc  o
 o tati  FR2, r g form H erface
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In the first study we examined the possibility to select for stability during the 
phage display procedure. Phage display was performed for the selection of VHHs against a 
cell surface protein of Malasezzia furfur (Malf1) under physiological conditions (PBS). 
This resulted in a large pool of VHHs specific for Malf1. However, the application of these 
VHHs required functionality in high concentrations of shampoo. The selected VHHs were 
shown not able to bind to Malf1 in low amounts of shampoo. Therefore, phage display in 
the presence of shampoo was performed and this resulted in VHHs which were able to bind 
to Malf1 in shampoo, indicating a significant increase in stability of these VHHs. 
Investigation of the protein sequences of these VHHs revealed that residues in the ‘former’ 
VH-VL interface contained a few substitutions which do not occur very frequent in VHHs.  
Residue Q/E44 is one of the four residues considered as a hallmark for the VHHs, 
constitutively substituted compared to the G44 present in most VHs. In the VHHs selected 
in shampoo R44 was found in several good binders. Mutations Q44R led to increased 
stability in shampoo, while R44Q decreased stability significantly (see chapter 2). 
Furthermore, R44K did not influence binding in shampoo. The binding in shampoo was 
diminished at pH 11, where K44 is less protonated. This revealed that the positive charge of 
R44 is responsible for the stability in shampoo.  
This confirmed previous observations that charge is important in this area of the 
VHH. The conserved hydrophobic stretch KGLEW of VHs, is replaced by KEREF/L in 
VHHs. Investigation of the crystal structure of the shampoo selected VHHs did not reveal 
any major structural changes yet, which could explain the increased stability in shampoo. 
Residue T43, which also occurred in several PBS selected VHHs, was highly conserved in 
the shampoo selected VHHs. Closer investigation of this KEREF/L region in stability is 
necessary to shed light on the role of charge in this area.  
4. Proteolytic stability 
ance the proteolytic 
stability f a VHH neutralizing rotavirus. VHH1 was shown to be able to inhibit rotavirus 
in vitro and in vivo (Van der Vaart, in preparation).  To come to an economically feasible 
product for developing countries for decreasing the deleterious effects of rotavirus, all 
3. Mutations to increase stability 
 
In a second study a mutational screen was performed to enh
o
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d. In this study the goal was to decrease the 
susceptibility for trypsin. Mutant R27A showed increased stability against trypsin, 
increase
Two other mutants were made in the ‘former’ VH-VL interface. First mutant 
certain mutations may not have significant effects on stability.  
also  decreased.The intracellular fraction of the yeast cells producing this mutant did show 
 
titutions K43T, and E44R, were 
oor. In order to see whether low production was caused by improper folding of the protein 
RNA expression was determined. The mutant VHHs  show a 
dramatic decrease in mRNA stability (figure 1). 
Figure 1 shows that the mRNA expression of mutant H14M (K43T and E44R) is 
 
features of the VHH should be optimise
d thermostability, increased production levels and equal affinity compared to the 
wildtype.  
R45A did not show any dramatic changes. Trypsin susceptibility was not affected, affinity 
was not affected, production levels were slightly decreased and thermostability was slightly 
decreased. This indicates that despite the high conservation of  R45, 97% (see table1), 
Mutation of position K43, which is also highly conserved, 86%, did show dramatic  
effects on stability. While T43 was present in 4% of all VHHs, K43T resulted in very low 
production levels, due to intracellular accumulation. Thermostability of this mutant was 
VHH accumulation on a coomassie stained gel, however, this fraction could not be purified, 
probably due to aggregation. This indicates that secretion is severely hindered, which could 
be caused by improper folding.  
5. Instability of RNA 
In a third study the mutations beneficial for stability of VHHs in shampoo 
observed were tested on other VHHs. Selection in shampoo resulted in a number of VHHs 
with highly identical protein sequences and two characteristic residues, T43 and R44. 
However, this improved stability was not restricted to stability in shampoo, also stability in 
urea and guanidine-HCl was improved. In this light, VHH-H14, a VHH against the human 
chorionic gonadotropin hormone, and VHH-R2 against the azo-dye RR6 were mutated. 
Protein  production levels of double mutants, with subs
p
or decreased mRNA  levels, m
decreased three-fold compared to wildtype H14, and mutant R2M (K43T and E44R) more 
than two-fold compared to wildtype R2 mRNA levels. As a control experiment the mRNA  
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1 Northern blot of 
H14, R2 and two mutants. 
top corner the northern 
gure 2). This indicates that the mutations made caused no 
dramatic instability of the mRNA.  
all amount of mutant 
Unfortunately, the 
the RNA gel. In the right 
top corner the northern 
 
 
 
H14  H14M             R2    R2M H14 H14M                  R2     R2M
 
Figure
CNT*mm2 CNT*mm2 CNT/mm2 CNT*mm2 CNT*mm2 CNT/mm2 density
2
8
R2
R2M
loading control northern blot
In the left top corner the 
ribosomal bands as seen on 
the RNA gel. In the right 
Name Volume Adj. Vol. Density Volume Adj. Vol. Density Relative 
 
H14 71887.95 46296.98 255465.3 581228.5 556691.3 6703903 12.0
H14M 50506.13 24915.16 179481.6 116168.4 91631.25 1339889 3.6
blot. At the bottom the 
volume calculations and 
the relative densities. 
 
levels of VHHs against Malf1 were determined. Four VHHs, two containing 
T43R44 (D12 and A7M) and two containing T43Q44 (D12M and A7) showed roughly 
equal amounts of mRNA (see fi
71524.94 45933.97 254175.3 757993.5 733456.3 8742715 15.97
68413.16 42822.19 243117.1 291051.6 266514.5 3356996 6.22
Control 25590.96 0 90941.57 24537.19 0 283012.5
Despite the instability of the mRNA of H14M and R2M, a sm
VHH protein could be purified and was tested for stability in shampoo. 
results i
 D12    D12M    A7    A7M
ndicated that the mutations did not result in an increased binding in shampoo of 
VHH-R2 and VHH-H14. This indicates that while these residues have been shown to be 
important for stability in shampoo, they are not the sole determinants for this stability. 
 
 
Figure2  Northern blot of 
D12, A7 and two mutants. 
In the left top corner the 
ribosomal bands as seen on 
D12    D12M     A7     A7M
Name Volume Adj. Vol. Density Volume Adj. Vol. D
CNT*mm2 CNT*mm2 CNT/mm2 CNT*mm2 CNT*mm2 CNT
blot. At the bottom the 
volume calculations and 
the relative densities. 
71960.08 50884.08 246101.4 1611370 1543638 18585583 30.34
A7 68045.89 46969.88 232715 2017859 1950126 23274032 41.51
A7M 57624.28 36548.27 197073.4 1335602 1267869 15404862 34.7
Control 21076 0 72079.34 67732.78 0 781231.4
loading control Northern blot
ensity relative
/mm2 densities
D12
D12M 55499.76 34423.75 189807.6 1351415 1283682 15587246 37.3
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As codon usage was shown to have influence on the sta lity of mRNA (Gouka, 
1996) it could be that codon usage was not optimal for these muta s. The codons used in 
malf-D12 were ACC (T), CGG (R), and the codons used in H14M nd R2M were ACG (T) 
and CGG (R). Thus, codon usage for R44 could not have solely cau  the instability of the 
mRNA, although this codon was the least common codon for Arg (1.7 per 1000) used in 
Saccharomyces cerevisiae. Codons usage in Saccharomyces cere
(20.2), ACA (17.7), ACC (12.6), and ACG (8.0). The codon usage 
less preferable compared to codon usage of malf-D12 for produ
cerevisiae. This could be an explanation for the decreased stability 
mRNA stability is complex and this might not be the only reason fo
Mutant K43T of anti-rotavirus VHH1, constructed to incr
also showed dramatically decreased protein production levels. To e
mRNA stability caused the decreased production, as seen in the mutants of H14 and R2, 
levels of mRNA expression were determined. Figure 3 shows the Northern blot of the eight 
mutants 
that the hampered secretion was due to a problem on protein level and further supports the 
hypothesis that this mutation causes a folding problem. 
s of 
 In the left top 
e ribosomal 
 
bi
nt
a
sed
visiae for Thr was ACT 
for H14M and R2M was 
ction in Saccharomyces 
of the mRNA. However, 
r the instability. 
ease proteolytic stability, 
xclude that a decrease in 
produced for the mutational screen on decreasing trypsin susceptibility. 
Figure 3 shows there is no significant decrease of mRNA of mutant K43T. This indicates 
 
 
 
Figure 3. Northern 
blot of mutant
  C   R17S  R17A  R27F  R27A  K43T  K64A  K86A  R45A
VHH1.
corner th
C    R17S  R17A R27F R27A K43T K64A K86A R45A
Name Volume Adj. Vol. Density Volume Adj. Vol. Density relative
CNT*mm2 CNT*mm2 CNT/mm2 CNT*mm2 CNT*mm2 CNT/mm2 density
control 49143.95 23135.03 176269.5 NA NA NA
R17S 55850.76 29841.84 200325.5 293287.7 263675.7 4545334 1
R17A 53846.4 27837.48 193136.3 261696.4 232084.4 4055737 7.
R27F 48245.27 22236.35 173046.2 399910.9 370298.9 6197766 1
R27A 37726.85 11717.93 135318.7 291666.2 262054.2 4520204 11.
K43T 55411.94 29403.02 198751.6 174869.6 145257.6 2710105 1
K64A 48851.53 22842.61 175220.7 181309 151697.1 2809904 5.
K86A 45084.04 19075.12 161707.5 238131.8 208519.8 3690535 9.
R45A 52131.41 26122.49 186985 161803.1 132191.1 2507604 6.
empty 26008.92 0 93288.81 29611.99 0 458922.8
bands as seen on the 
RNA gel. In the right 
top corner the 
northern blot. At the 
bottom the volume 
calculations and the 
relative densities. 
1.4
78
3.3
78
2.4
16
13
93
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onclusions 
 
rophilicity. 
Hs. Investigation of the residue 
distribution showed the highest rate of substitutions in this area. G44Q/E (8 ), L45R 
(97%), and W47F/L/G (84%). Furthermore, mutations of position 43, 44 and o a lesser 
extent) 45 had dramatic effects on stability. This suggests that these residues have a key 
role in the stability of the VHHs. 
  
Material and methods 
 
Distribution of residues in VHH 
A MySQL database containing 703 public and proprie
sequences, primarily llama sequences, was queried based on residue an
occurance of each residue was determined for each position. 
C
Residues in the VH-VL interface are highly conserved in conventional antibodies. 
These residues are usually large, hydrophobic and aromatic residues in the VH, with the 
specific function of interacting with the VL and formation of the binding cleft. Without any 
further practical knowledge one could easily assume that these residues in VHHs, lacking 
the VL, are less important and will therefore be less conserved. In this respect, it is clear 
that these residues in VHHs have a higher variability. Nevertheless, the importance of these 
residues is shown by the unique properties obtained by substitution of the hydrophobic 
residues into more hydrophylic and often charged residues. High solubility and thereby 
high production levels in microorganism is just one example (Frenken, 2000). 
A peculiar exception to these substitutions from hydrophobic to hydrophylic 
residues is W103. This large aromatic and very hydrophobic residue is seen in 96% of all 
VHHs as well. This implicates a different role for W103 in VHHs compared to the other 
residues in the ‘former’ VH-VL interface. 
The substitutions observed from VH to VHH clearly increase the hyd
Here, we provided evidence for a broader function of the residues in the ‘former’ VH-VL 
interface. We claim that these residues, especially the residues in the hydrophilic KEREF/L 
stretch are key determinants for the stability of VH
7%
(t
tary camelid VHH 
d kabat number. The 
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t 
Yeast cells were disturbed with 0.45 mm glass beads in phenol and RNA 
extraction buffer (50 mM Tris pH 7.4; 100 mM NaCl; 10 mM EDTA) in a Bead Beater 
(Biospecs Products Inc.) to isolate total RNA. A phenol/chloroform extraction was 
performed, and subsequently total RNA was precipitated by adding 3 M NaAc pH 5.6 and 
ethanol. RNA was washed with ethanol, air-dried and resuspended in ddH2O. Ten µg of 
total RNA with 2  µl ethidiumbromide was loaded on a 1% denaturing formamide/ 
formaldehyde gel. Total RNA was separated by electrophoresis and ribosomal bands were 
visualised with an Imago gel imaging system (Isogen Life Science, Maarssen, The 
Netherlands). RNA was transferred to Hybond-N membrane (Amersham Pharmacia 
Biotech) and cross-linked using a UV-stratalinker (Statagene). Probes against VHH-H14, 
VHH-R2, anti-Malf VHHs and anti rotavirus VHHs was obtained by PCR. 25 ng of 
purified PCR product was used for incorporation of 50 µCi 32P-CTP (Amersham) using the 
Prime-a-Gene labelling system (Promega) according to the manufacturer’s protocol. 
Unincorporated 32P-dCTP was removed using NICK columns (Pharmacia) according to the 
manufacturer’s instructions. The blots were incubated for prehybridisation in hybridisation 
mixture (1mM EDTA; 7% SDS; 0.5 M NaPO4 pH 7.5) for one hour in a micro-4 
hybridisation oven (Biozym) at 45 °C. Probes were added and hybridised overnight at 45 
°C. Subsequently, blots were washed once in 2X SSC at room temperature for two minutes, 
twice in 2X SSC, 0.1% SDS, 0.1% NaPPi for 20 minutes at 45 °C, and once for 20 minutes 
in 0.5X SSC, 0.1% SDS, 0.1% NaPPi at 45 °C. After a final wash with 2X SSC at room 
temperature, the membrane was wrapped in Saran (Dow Chemicals), and autoradiograms 
were developed using hyperfilm MP (Amersham). To quantify the RNA levels, blots were 
exposed for autoradiography and signals quantified using a BioRad Molecular Imager FX 
(BioRad, Veenendaal, the Netherlands). Volume calculations were performed using 
Quantity One software (Bio-Rad, Veenendaal, the Netherlands). Relative densities were 
determined using the volumes of the ribosomal bands as a control. S. cerevisiae codon 
usage was obtained from http://www.chem.ucla.edu/~pdoucett/icosa/Yeastcode.html. 
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 this thesis the stability of llama heavy chain antibody fragments, VHHs, was 
investigated under several extreme conditions. Survival of these conditions or functionality 
under these conditions can be necessary for the application of VHHs in consumer goods, 
 antibodies are used are numerous 
nd still increasing. Every application has its specific demands concerning the stability of 
eficial 
roperties compared to conventional antibodies. 
VHHs have unique characteristics at high temperatures. They were already shown 
 be functional after a heat shock of two hours at 90°C (Van der Linden, 1999) and were 
likely to be direct benefits from the single domain status. Chapter two describes that VHHs 
re able to refold to their native conformation even at 80°C, induced by addition of the 
ty binding 
under normal conditions. The high stability of the antigen-antibody complex is one reason 
for the fast and complete refolding of the VHH population. The other reason for this 
phenomenon is most likely refolding of the temperature denatured antibody directly 
induced by binding of the antigen to the unfolded VHH, as described in chapter 2. An 
interaction between a peptide comprising CDR3 and the antigen was observed. This 
observation together with the remarkable refolding at high temperatures could indicate that 
there is an interaction between CDR3 in the unfolded VHH and the antigen, which could be 
a catalyst for the formation of the native antibody-antigen complex. Long range interactions 
within the VHH necessary for correct folding are more likely to occur, caused by 
stabilisation through binding of the antigen.  
The refolding capacity, even under extreme conditions, also implies that the 
functionality of VHHs only decreases when irreversible denaturation caused by 
General discussion 
 
In
process aids and research tools. The applications in which
a
the antibodies, either in the application itself or in the line of process. The VHH, being the 
smallest naturally occurring binding unit,  is already privileged with many ben
p
 
Temperature stability 
to
able to refold after heat denaturation (Perez, 2001). These unique properties of VHHs are 
a
antigen. They were able to form a stable antibody-antigen complex at high temperature. 
The only condition for the refolding at these high temperatures is a high affini
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aggregat , caused 
by paste leterious 
for conv  this is a 
great advantage when using VHHs in applications where these heat shocks are required. 
The first signs are already emerging that this mechanism also holds true for stability in 
her denaturing conditions and is not reserved to only reversible temperature unfolding.  
election and screening 
Several advantages of VHHs, like the good solubility and the refolding capacity, 
are intrinsic properties of VHHs. On the other hand, other advantages are abilities of a 
all population of VHHs, either already present or easily incorporatable. When present it 
HHs, in order to find the VHH with the 
opulation of VHHs binding to a dye 
y two VHHs were able to bind RR6 at 
90°C (Van der Linden, 1999). If functionality at 90°C is required, like in laundry products, 
selection or screening for these properties will be necessary. In chapter 3 a successful 
method is described in order to select for beneficial properties of VHHs. Applied phage 
isplay has been shown to be able to efficiently select for stability in a desired environment, 
 this case high concentrations of shampoo.  
Phage display with VHHs is a unique combination. In vivo maturation of the 
ntibody fragments by immunisation is combined with easy cloning. For this reason highly 
iverse libraries can easily be constructed for almost any antigen. Several tricks, like 
elution with specific domains or competitors to select for specific epitopes, decreasing 
antigen concentration for the selection towards high affinity binders or the use of counter-
selections for ridding binders on unwanted epitopes, make the selection procedure very 
flexible. The flexibility in the selection allows for efficient and large-scale selection of the 
desired VHH in a relatively short time. Therefore subsequent laborious protein engineering 
can be minimised 
Phage can be the rate limiting step in the phage display procedure. It is possible 
that the VHH survive the extreme condition applied during the selection procedure and are 
able to bind to their antigen, but because of disruption of the phage, the phage-VHH couple 
is no longer able to reinfect bacteria after selection. In this scenario one could miss efficient 
ion, proteolysis or chemical degradation has occurred. Heat denaturation
urisation or sterilisation of food products containing antibodies, can be de
entional antibodies. VHHs are able to survive these harsh conditions and
ot
 
S
sm
is necessary to select for this small population of V
desired properties. Van der Linden showed that in a p
R6, with relatively high sequence similarity, onlR
d
in
a
d
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oo could be considered as an extreme condition. On the 
other ha  the addition of pepsin during the selection procedure for rotavirus inhibiting 
VHHs s
One way of incorporating beneficial properties into VHHs is by protein 
engineering. DNA shuffling (Van der Linden, 2000), random mutagenesis (der Maur, 2002) 
able frameworks or other scaffolds (Jung, 1997) are methods 
used fo
uent screening on inhibition of rotavirus in 
vitro  res
and anionic surfactants in shamp
nd
howed a loss of recovered phage after selection. This may have been caused by 
digestion of the protease sensitive link between VHH and phage (Van der Vaart, 
manuscript in preparation). On the other hand, a large population of phage-VHH 
combinations were still present. Specific binders and inhibitors of rotavirus could be 
obtained, which are stable in the environment of the gut, including pepsin. 
 
Protein engineering 
or grafting CDR loops on st
r improvement of antibodies. Site-directed mutagenesis requires structural 
knowledge from previous experiments and observations (Davies, 1996). 
The high homology of the VHH domains and the rising structural knowledge of 
these binding blocks make protein engineering an appreciated tool for the improvement of 
VHHs. However, it has been shown that beneficial mutation of a residue in one VHH does 
not necessarily have to be beneficial to the other. Chapter four describes the improvement 
of a VHH by a mutational analysis. In this study we inserted a mutation which was present 
in a subpopulation of VHHs stable in shampoo and urea to enhance the properties of this 
VHH. However, where mutation K43T was beneficial for VHHs binding Malf1 in 
shampoo, it was deleterious for the secretion and probably the folding of VHH1 binding 
rotavirus.  
Mutant R27A was found to be a good candidate to become an economically 
feasible product in developing countries for the reduction of the incidences of rotavirus 
infection. This mutant was obtained in a relatively short time and its properties are already 
excellent for the use in the gastrointestinal tract. First, a pool of VHHs was selected via 
phage display in the presence of a low pH and pepsin. This reinsured the stability of the 
VHHs in the environment of the gut. Subseq
ulted in a population of VHHs able to inhibit rotavirus. In order to be functional in 
the intestine trypsin stability was improved via protein engineering.  
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st 
leavage site. The Frenken-accessibility plot could therefore be a very efficient tool to 
 serine-proteases in proteins.  
We still do not know what the boundaries are to the applications of the VHHs. 
They can be reused on a affinity chromatography column for over 2000 times without loss 
of capacity (Verheesen, 2003). They can be used under denaturing conditions often used in 
biochemical studies, can be coupled easily and site specific, and are therefore excellently 
suitable for protein arrays (Zhu, 2000; Haab, 2003). They can be used to combat 
bacteriophage infections in dairy plants (Ledeboer, 2002; de Haard, accepted for 
publication). The uniqueness lies in the flexible selection procedure and the ability to select 
that one binder which has all the properties needed for your application.  
Homology modelling and the introduction of the Frenken-accessibility plot to 
qualitatively predict which arginines and lysines are most susceptible to tryptic digestion, 
resulted in a small group of possible beneficial mutants (Dolk, submitted for publication). 
This method proved to be very efficient, the mutant which was most likely to improve the 
properties of the VHH was shown to be the first cleavage site for trypsin. As shown before 
the stability against trypsin cleavage increased dramatically after removal of this fir
c
predict the first cleavage site of
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in vitro antigen selection of camelized, human VH domains with improved protein stability. Protein 
Pluckthun, A., and Barberis, A. 2002. Direct in vivo screening of intrabody libraries constructed on a 
d applications of antibody microarrays in cancer research. Proteomics 3: 
2116-2122. 
 
Lactococcus lactis in 
ma. J Dairy Sci 85: 
1376-138
L., Wilson, S., Davis, P., and Verrips, C.T. 1999. Comparison of physical chemical properties of 
Van der Linden, R.H., de Geus, B., Frenken, G.J., Peters, H., and Verrips, C.T. 2000. Improved 
productio
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ntibodies consequently have unique properties. A high stability is one of these properties, 
hysiological environments. High temperature, anionic and non-ionic surfactants in 
 the stability of the VHHs.  
. Stability in the previous sentence 
ust be regarded as functionality under these conditions. In chapter 2 we showed that 
lation of VHHs is unfolded at 80 ºC. However, after addition of the antigen, 
ain of the VHHs is the logical cause of the ability of refolding and 
nd their intrinsic stability.  
marks for VHHs, making the ‘former’ VL interface  highly 
 involved in making the 
le in the stability of the VHHs. 
Summary 
Camelids have next to their normal antibodies, a unique subset of antibodies 
lacking light chains. The resulting single binding domain, VHH, of these heavy chain 
a
which was investigated in this thesis.  
The applications in which these VHHs are to be used, require functionality in non-
p
shampoo,  and the low pH and digestive enzymes of the gastrointestinal tract put high 
demands on
Regardless of these harsh conditions, the VHHs seem to exceed conventional 
antibody fragments and are known for their high stability
m
VHHs can be functional at high temperatures, despite of the fact that they were already 
unfolded at high temperatures. Unfolding of the VHH population started at 60 ºC, and most 
of the popu
complete refolding and complex formation was observed. This shows the fast and highly 
efficient refolding of the VHHs, which can be of use in a wide range of applications. 
The single dom
explains why refolding is not observed in more complex antibodies, being composed of 
several domains, which are not able to refold properly. This refolding property of VHHs, 
together with the low degree of aggregation, implies that these VHHs can be functional 
beyo
The adaptations to the single domain status shown by VHHs,  reside 
predominantly in the region where in conventional antibodies the VL is attached. Four 
substitutions are hall
hydrophilic. Furthermore, chapter five describes that more substitutions can be observed 
from VH to VHH. Most of these substitutions are from large hydrophobic residue to 
hydrophilic (charged) residues.  These substitutions are not only
VHH more soluble, in chapter three and four two mutational studies are described which 
indicate that the residues in this so-called ‘former’ VH-VL interface could also have a 
prominent ro
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shampoo by addition of shampoo to the selection protocol. The VHHs obtained from this 
selection were investigated and the protein sequences show that selection is driven towards 
a small subclass of VHHs. This subclass exceed other VHHs for stability in shampoo, 
indicating that selection was directed towards stability in shampoo. 
This technique was used in a second study to ensure stability of VHHs in the 
environment of the gut. VHHs against rotavirus were selected at low pH and in the 
presence of pepsin. To further enhance the stability of the selected subclass of VHHs, 
protein engineering was used to ensure stability in the intestine. A mutational study was 
performed to remove trypsin cleavage sites from the VHH. Mutant R27A showed a reduced 
trypsin susceptibility. Furthermore, this VHH also showed increased production levels, 
increased thermostability and equal affinity compard to the wildtype VHH1.  
These results show that VHHs are ideal candidates for a wide range of 
applications. As shown in this thesis, the high stability of these VHHs, together with the 
rapid and easy selection methods, and subsequent improvement by protein engineering, 
results in exquisite opportunities for application in harsh conditions. 
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ng in het Nederlands 
 
tiging van de antigenen via een cascade van 
gebeurte
toepassing van antilichamen in wasmiddelen, voor 
het voor
de 
eiwitdom
ormale antilichamen zullen extreme omstandigheden niet 
kunnen 
. In hoofdstuk vijf staan een aantal van deze 
Samenvatti
Het immuunsysteem heeft de taak om ons lichaam te beschermen tegen 
pathogenen, zoals virussen en bacteriën. Antilichamen hebben een belangrijke taak in dit 
proces. Ze herkennen de niet-lichaamseigen stoffen (antigenen), binden aan deze antigenen 
en zorgen hiermee voor de vernie
nissen. De primaire eigenschap van antilichamen is het specifiek binden van de 
antigenen met een hoge affiniteit. Deze eigenschap maakt antilichamen bruikbaar in 
toepassingen buiten het lichaam, in zowel de industrie als de wetenschap. In dit proefschrift 
staan voorbeelden beschreven voor de 
komen van roos en voor de inhibitie van rotavirus infectie. 
Voor de toepassing van antilichamen in producten is het van belang dat deze 
antilichamen functioneel zijn buiten hun “normale” omgeving, de fysiologische 
omstandigheden van het bloed. Hoge temperaturen nodig voor sterilisatie of pasteurisatie, 
hoge concentraties zeep in shampoo of de zure omgeving van het maagdarmkanaal met alle 
aanwezige stofwisselingsenzymen mogen aangemerkt worden als extreme omstandigheden 
voor antilichamen. 
Antilichamen zijn complexe eiwitten die opgebouwd zijn uit verschillen
einen (zie figuur 1 van de introductie). Twee van deze domeinen, de variabele 
domeinen vormen samen het bindende deel van het antilichaam. Deze domeinen bestaan uit 
strengen van aminozuren die op een zeer specifieke manier gevouwen worden waardoor er 
drie loops per domein ontstaan die samen zorgen voor de specifieke binding van het 
antilichaam aan het antigen. N
weerstaan omdat de specifieke vouwing van onder andere deze variabele 
eiwitdomeinen verloren gaat. Door de ontvouwing zullen de domeinen makkelijk kunnen 
aggregeren en niet meer terugvouwen naar hun oorspronkelijke conformatie. Hierdoor 
verliest het antilichaam zijn bindende capaciteit en is niet meer functioneel. 
Lama’s, kamelen en dromedarissen bezitten naast deze “normale” antilichamen 
een bijzondere klasse antilichamen. Deze zware keten antilichamen missen de zogenoemde 
lichte keten, wat tot gevolg heeft dat het bindende deel van deze antilichamen bestaat uit 
slechts één domein. Er is aangetoond dat dit domein, VHH, zich aangepast heeft aan het 
ontbreken van het tweede bindende domein
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aanpassi
elijkheden, welke ook 
compens
r hervouwing 
bij 80 ˚C
rgt voor selectie van 
VHH’s met hogere stabiliteit in shampoo.  
In hoofdstuk vier staat de optimalisatie van een VHH voor het gebruik in het 
maagdarmkanaal beschreven. Een VHH tegen rotavirus is geselecteerd op stabiliteit in zuur 
milieu en pepsine (maag), volgens de methode beschreven in hoofdstuk drie. Hierna is de 
stabiliteit tegen trypsine (darmen) verbeterd door gerichte mutaties aan te brengen. De 
unieke combinatie van deze technieken heeft geleidt tot een VHH met verbeterde 
eigenschappen qua trypsine stabiliteit, productie, temperatuur stabiliteit en gelijke affiniteit. 
Dit maakt deze mutant een goede kandidaat voor een economisch rendabel product voor de 
remming van rotavirus infectie, zelfs voor toepassing in derde wereld landen.  
 
ngen beschreven. Op sequentieniveau is gekeken naar de verschillen tussen 
normale en lama antilichamen. De conclusie is dat hydrofobe aminozuren vervangen zijn 
door hydrofiele aminozuren om aggregatie te voorkomen. Met name de regio waar normaal 
het tweede domein geassocieerd is laat deze aanpassingen zien. Daarnaast zorgt een langere 
derde bindingsloop van de VHH’s voor unieke vouwings-mog
eren voor het gebrek van het tweede bindingsdomein. Dit maakt de VHH 
gelijkwaardig aan normale antilichamen op functioneel gebied. 
In hoofdstuk twee, drie en vier staan voorbeelden beschreven van de toepassing 
van deze antilichamen onder extreme omstandigheden. In hoofdstuk twee is gekeken naar 
de stabiliteit van deze antilichamen bij hoge temperaturen. VHH’s zijn ontvouwen bij 80 
˚C, maar zijn in staat om terug te vouwen door de aanwezigheid van het antigen. Het 
ontvouwen antilichaam kan een interactie aangaan met het antigen, waardoo
 efficiënt kan verlopen. 
In hoofdstuk drie staat een selectiemethode beschreven die gebruikt kan worden 
om VHH’s te selecteren voor de toepassing onder extreme omstandigheden. Aangetoond is 
dat selectie met faag display in de aanwezigheid van shampoo zo
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rgeten. Daarom wil ik 
iedereen
iacore, de koffiepauzes, overhoringen over DNA isolatiekits, het 
ontdooie
Dankwoord 
Het dankwoord, het enigste stuk van dit proefschrift, dat niet gecontroleerd wordt 
op spelfouten en onwaarheden. De afsluiting van vier bewogen jaren. Daarbij doel ik dan 
trouwens niet op de verhuisexpertise die ik opgedaan heb. Van Unilever naar Utrecht 
verhuist, van de oostvleugel midden tussen de MCBers gepropt, van de MCBers naar de 
gisten gestuurd, van de gisten weer terug naar N532. Nee, vier bewogen jaren omdat er in 
mijn simpele leventje zoveel gebeurd is, met als prachtige afsluiting dit proefschrift waar ik 
ontzettend trots op ben. 
Ik kan zoals velen een enorme lijst van namen gaan produceren die me geholpen 
hebben, maar verstrooid als ik ben zal ik een hoop mensen ve
 bedanken die ook maar iets heeft bijgedragen aan dit boekje, maar vooral ook 
gezelligheid brachten naast het werk. In Vlaardingen waren die mensen in overvloed, 
denkende aan het kerstdiner met de kerstborrel, SPDB invullen, de altijd rijkelijk gevulde 
sinterklaaslunch, de SPQR zaalvoetbalpotjes, de speurtocht in Amsterdam, de zuiveringen 
op de protein A kolom, klimmen bij de Neeltje Jans, SOPS maken, de labtap avonden, het 
vechten met de B
n van de vriezers, het karten, de rondleiding door Naarden, de roddelpraat, 
allemaal bedankt. Ik heb me altijd heel erg thuis gevoeld in Vlaardingen. 
Bij de MCB moet ik vooral denken aan de kanotochten, de borrels, de roulette, de 
nieuwjaars spelletjes, Boom Chicago, de filmavonden, zoeken naar golfhoogtes in Zeeland, 
het snaken, de speurtocht door Amsterdam, de optredens van Bartenders Advice, het 
badmintonnen in de zomer, etentje met Adri, het zeilen in Langweer, de “studenten afmaak 
voetbal wedstrijden”, met Fons als scheidsrechter !?, de wandelingen naar de Spar, pizza 
eten aan de koffietafel, de inspirerende werking van de muziek van The Beatles, het 
uitvinden van Lamalon, eten in het educatorium, het vechten om de radiozender, het vullen 
van de autoclaaf, alle studentenprojectjes. 
Maar ook de mensen die het leven buiten het werk aangenaam maakten, zoals met 
stapavondjes in de EKKO of Tivoli, de SAM (shit, alweer mis) dartavonden, mijn 
fantastische kaartmaat Edward en de goede verliezers, de Bassen, gezellige festivals, 
ontspannende saunabezoekjes, hartverwarmende herenigingen met kabouters, leuke 
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Jappie, Pim, Sandra, Marcel, Leon, Janice, John, Paul, 
Johanne
 nog heel veel mensen van gaan genieten. Ilse, 
Rinse, P
o sterk ben 
omdat ik dat van jou geërfd heb.  
Als laatste natuurlijk mijn vrouw, Joyce, je was er altijd voor me, op de leuke 
momenten om met me te lachen en gek te doen en op de moeilijke momenten om me te 
steunen. Ik hoop dat we dat nog heel lang voor elkaar kunnen blijven doen. Poepie, je bent 
het einde. 
 
 
concerten, fijne verjaardagen, een geweldige trouwerij, voetballen bij sportvereniging van 
het jaar Odysseus, heerlijke relax-weekendjes, volleyballen in Scheveningen, veel 
spelletjes, iedereen die zich aangesproken voelt, ook jullie allemaal bedankt. 
Daarnaast wil ik nog een aantal mensen persoonlijk bedanken. Theo, bedankt voor 
alles. Met als hoogtepunt een weekje schrijven in, het inderdaad prachtige, Besse, heb je 
altijd voor me klaar gestaan en heb je me weten te stimuleren. De tijd om te oogsten is 
begonnen en het is een goed jaar. 
Gert, ook bij jou heb ik een weekendje mogen bivakeren om op de valreep nog 
wat schaafwerk te verrichten, bedankt voor je gastvrijheid. Sorry dat ik je een heel weekend 
achter Windows heb gezet, en dat met een bioloog, dat moet zwaar voor je zijn geweest. 
Mijn paranimfen wil ik bedanken dat ze de zware taak om mij te helpen op mijn 
promotie op zich wilden nemen en zich zelfs daarvoor in pak willen hijsen. 
Ook Hans, Rob, Arie, 
s, Jord, Michiel, Adri, Christian, en velen, velen meer bedankt voor de nodige 
wetenschappelijke discussies en adviezen.  
Verder wil ik het hele lamateam bedanken. Ik ben heel erg trots op het mooie labje 
dat we hebben ingericht en ik denk dat er
eter, David en natuurlijk alle andere AiO’s succes met afronden. Mijn studentjes 
Nathalie en Gerold bedankt voor al het werk dat ze gedaan hebben en de gezelligheid die ze 
gebracht hebben, ik heb van jullie genoten.  
Alle familie, schoonfamilie en vrienden wil ik bedanken voor de nodige afleiding, 
gezelligheid en interesse die ze getoond hebben. Jullie zijn allemaal erg belangrijk voor me, 
hoe meer vrienden, hoe meer vreugde, ik kan het weten. Natuurlijk mijn broertje met 
aanhang, je bent altijd een grote steun voor me geweest. Pa, ik weet dat je trots op me bent. 
Ma, bedankt voor alle steun en liefde die je me gegeven hebt, ik weet dat ik z
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